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 Summary 
 
The use of antibiotics as growth promoters has characterized the development of 
livestock productions for more than 50 years. Consumer and political opinions, and a 
scientific concern that resistance to antibiotics selected in animals might be transmitted 
to human pathogens, affecting the efficacy of the pharmacological treatment, created a 
great debate in Europe which led to a complete ban of AGP in 2006. However, the 
correlation between the development of antibiotic resistance in bacteria and the 
agricultural usage of antibiotics has never been clearly demonstrated or supported by 
evidence.  
In pig production systems, the main consequences of the ban were a transient 
impairment of animal welfare and growth performance, particularly after weaning, and 
economic losses related to increased production cycles length and veterinary expenses.  
As reported by Lallès et al. (2009), various nutritional approaches aimed to the 
optimization of the weaning transition and reduction of the GIT diseases have been 
proposed, but the success rates are really low compared to antimicrobials. Nutritional 
strategies and adoption of breeding management focused on disease prevention are 
fundamental to counteract the spread of infectious disease in food animals, especially in 
intensive farming. However, the search for successful alternatives is hampered by a lack 
of knowledge about the mechanisms of the antibiotics-mediated growth enhancement. 
AGP have been considered for a long time as acting essentially on the gut microbiota, 
by reducing the potentially harmful effects of the intestinal microbiota. A recent theory 
suggested an anti-inflammatory role of AGP compounds, which caused a down 
regulation of the immune response, thus allowing a larger amount of energy available 
for the animal growth. Immunomodulating compounds are gaining interest, since the 
correct development of both innate and acquired immune system of the piglets is a key 
factor in determining the outcomes of a large exposure to antigens and stress conditions, 
typical at weaning. 
Moreover, nutrition has become a tool to improve health and wellness in both humans 
and animals, due to the health promoting activities of particular compounds, e.g. β-
glucans, lycopene, ω3 or conjugated linoleic acid, present in food and feed.  
The antisecretory factor protein (AF) is secreted in plasma and other tissue fluids in 
mammalians. It was shown to be a potent inhibitor of intestinal fluid secretion and 
inflammation; its immunohistological distribution suggested a role in the immune 
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 system. AF content in sows’ milk appears to be a protection factor against neonatal 
diarrhoea in suckling piglets. Exposure to bacterial toxins induces secretion of AF in 
plasma, probably reflecting a natural defence mechanism to agents causing diarrhoea, 
thereby contributing to a favourable clinical outcome and disease termination. Increase 
of AF level in plasma by dietary means, such as feeding hydro-thermally processed 
cereals (HPC), has been demonstrated in human and animals. Nevertheless, the 
mechanism of action behind its biological activity has not yet been clarified and, so far, 
few data are available on pig field trials. Furthermore, compared to its use in human 
nutrition, the proper level of HPC diet supplementation has not been defined. 
A first purpose of this thesis has been to summarize the knowledge on the antisecretory 
factor and its derivates, evidencing the potentially beneficial effects of AF-inducing 
diets on both human and animal health and welfare.  
In the field trial we tested the effects of two HPC level of diet supplementation (3% vs 
6%) on weaned piglets growth performance and intestinal mucosa health status. The 
results confirmed the efficacy of HPC as growth promoters in piglets: compared to the 
3% supplemented diet and the control group, 6% of HPC supplementation improved 
ADG and feed conversion rate. In vitro digestion assays of the diets evidenced relevant 
simple sugars content and a higher rate of starch hydrolysation in the HPC diets 
compared to control diet. The difference in growth performance observed between 
groups might be related to a balanced supply of energy-yielding nutrients and amino 
acids in the diets. Indeed the first week post weaning is characterized by reduced 
voluntary feed ingestion and reduced pancreatic enzymes activity, therefore feeding a 
diet with highly digestible starch guarantees a correct amount of energy, limiting the 
amount of starch available for microbial fermentation in caecum and colon. In the 
current study the concentration of I-FABP in plasma were low in all groups and not 
affected by the dietary treatments, suggesting that, in good hygienic conditions, the 
dietary treatments did not affect small intestinal integrity. 
In vitro test were realized to investigate the antisecretory and the anti-inflammatory 
properties of the AF protein and its mechanism of action by using AF-16, a 16-meric 
peptide which contains the active domain of the protein.  
The Ussing chamber experiments were performed on polarized IPEC-J2 cells to 
investigate the antisecretory activity of AF-16. The peptide did not inhibit the CT-
induced Isc increase as did DPC, a voltage-dependent CFTR/Cl- blocker. A slower rate 
of Isc increase was observed during the simultaneous administration with AF-16 and 
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 CT. A recent study by Johansson et al. (2008) hypothesized that AF binding to the 
integral membrane protein flotillin-1, localized in the lipid rafts, causes an alteration of 
ion channels and receptors localization. It is possible to speculate that the effects 
observed on CT-induced Isc might be due to a kind of “disturbing effect” on the toxin 
binding to GM1, which is also localized in the lipid rafts.  
To evaluate the anti-inflammatory activity of AF, as a possible immunomodulating feed 
additive, two kind of in vitro assays were made. High dosages of AF-16 (1x10-4 M) 
were found to reduce the LPS-stimulated NO production in RAW264.7 cell, thus 
supporting the hypothesis of an anti-inflammatory action. The effects observed could be 
due to the blockage of LPS activity and consequently the iNOS inhibition. Moreover, 
the presence in the peptide sequence of cysteine, which contains a SH group, and 
proline, which is a well known free-radicals scavenger, may act as a scavenger for 
unpaired electrons, thus reducing free radicals generation. On the contrary, no 
significant results were obtained on PMA-stimulated ROS generation in pig alveolar 
macrophages. 
The literature review showed how the AF-inducing diets and the AF-therapy is an 
interesting approach to improve welfare in humans affected by several disease 
Cereals might also be helpful for people subjected to the risk of intracranial pressure 
increase, i.e. patients affected by brain pathologies like tumors in conditions of sudden 
pressure changes, as during long flies, or exposed to overpressure as divers. AF-rich egg 
yolk powder gives the opportunity of a direct and fast AF administration to young 
children and to people with impaired food consumption. 
It is remarkable that the hydrothermally processed cereals, being simple cereals kernels, 
may have a positive image towards the modern European consumers, who are 
increasingly sensitive to ethical considerations and whose opinion has a great influence 
on legislation. Compared to other possible alternatives to antimicrobial growth 
promoters, these processed cereals do not contain any active compound that can be lost 
in the upper gut, since their action is to stimulate the animal capability to produce it. In 
addition, we found that HPC supplementation improved the feed conversion rate: a 
more efficient use of nutrients present in the diet allow decreased nutrition costs and 
reduced nitrogen and phosphate excretion in manure and their accumulation in the soil.  
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 List of abbreviations 
 
5-HT 5-hydroxytryptamine 
ADFI average daily feed intake g/day 
ADG  average daily gain g/day 
AF antisecretory factor 
AF-16 antisecretory factor peptide (16-mer) 
AGA Amylogucosidase test 
AAO-HNS American Academy of Otolaryngology-Head and Neck Surgery 
BW  body weight 
cAMP cyclic adenosine monophosphate 
CD Crohn Disease 
CDA Clostridium difficile Toxin A 
CFTR Cystic Fibrosis Transport Regulator 
CNS Central Nervous System 
CT cholera toxin 
CP crude protein 
DHR 123 dihydrorhodamine 123 
DPC diphenylamine 2-carboxylic acid 
EAE Experimental autoimmune encephalomyelitis 
EEA Essential amino acids 
FCR feed conversion rate 
GABA gamma-Aminobutyric acid 
GIT gastrointestinal tract 
GM1 Monosialotetrahexosylganglioside 
HPC hydrothermally processed cereals 
IBD Inflammatory bowel disease 
IBS Irritable bowel syndrome 
ICP intracranial pressure 
I-FABP intestinal fatty acid binding protein 
IL Interleukin 
iNOS inducible nitric oxide synthase 
Isc short circuite current 
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 LPS Lipopolysaccharide 
LT labile toxin 
MHC II major histocompatibility complex class II 
MTC Medullary Thyroid Tumor 
NO  nitric oxide 
PMA phorbol myristate acetate 
PWDS post weaning diarrhoea sindrome 
rAF recombinant antisecretory factor 
ROS reactive oxygen species 
SBS short bowel syndrome 
SD standard error 
SDP spray dried plasma 
SEM mean square error 
SGLT 1 sodium-dependent glucose transporter 1 
TEER transepithelial electrical resi stance 
TNF-α tumor necrosis factor alpha 
UC Ulcerative Colitis 
VAS visual analogue scale 
VIP vasointestinal peptide 
VRE vancomycin-resistant enterococci 
vWm von Willebrand motif 
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 Antibiotic Growth Promoters in animal husbandry 
 
 
Introduction 
The introduction of antibacterial agents 70 years ago led to a revolution in the 
management of bacterial infections. The use of antimicrobials (commonly referred to as 
antibiotics), as growth promoters has characterized the development of livestock 
productions for more than 50 years.  
The growth promoting effect of antibiotics was casually discovered in the United States 
where dried mycelia of Streptomyces aureofaciens, containing tetracycline, added to 
poultry diet with the aim to increase vitamin B12 intake, improved the growth 
performances (Moore et al., 1946; Stokestad and Jukes, 1950). 
In 1951, the United States Food and Drug Administration authorized the use of 
antibiotics as feed additives; during the 1950s and ‘60s each European Country 
approved its own regulation about the non therapeutic use of antibiotic growth 
promoters (AGP) (Jones and Ricke, 2003; Castanon, 2007). 
From that time on, AGP became extensively used worldwide in livestock production, 
often being relied upon not only to enhance growth but also to substitute in part poor 
husbandry conditions (Soulsby, 2008). Added to the animal diets at sub therapeutic 
doses, AGP proved to be effective in improving feed efficiency and growth 
performance. The use of AGP prompted the intensive livestock productions and 
became fundamental to control and counteract the spread of infectious disease in farm 
animals. 
FAO considered that the sub-therapeutic employ of AGP significantly contributed to 
reduce animal protein deficiency in the world (Piva and Rossi, 1999).  
Animal breeding has undoubtedly drawn great advantages from the sub-therapeutic use 
of AGP mainly in young animals. Improvement of weight gain, feed efficiency and 
health status, reduction of environmental pollution, have been the most important results 
obtained.  
However, concerns about antibiotic resistance development which might be transferred 
to human pathogens, affecting the efficacy of the pharmacological treatment, created a 
great debate in Europe, though this correlation has never been clearly demonstrated or 
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 supported by evidence, their use became increasingly controversial until the complete 
European ban (Pradella, 2006).  
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 European regulation on AGPs  
 
During the ‘50s, resistance to tetracycline used at growth-promoting levels was 
observed (Dibner and Richards, 2005). 
The problem of antibiotic resistance linked to the use of AGP was dealt for the first time 
in the United Kingdom in the Swann Report in 1969. In order to reduce the risks of 
diffusion of antibiotic resistance between bacteria strains, the Swann report 
recommended a distinction between antibiotics used in human and veterinary medicine 
and those used as AGP (Swann, 1969). The debate created by the Swann Report led to a 
change in the European regulation on feed additives, with the adoption of the Council 
Directive on Additives 70/524. Since national regulations of each member State differed 
as regards basic principles, Dir 70/524 aimed at an harmonization of laws concerning 
additives in feeding stuffs, to establish and regulate the common market for animal 
feeds. Moreover, Dir 70/524 defined a list of antibiotic molecules authorized as 
additives in animal feeding and established a clear distinction between antibiotics for 
human and animal therapy and those used as growth promoters. 
In 1986, Sweden prohibited the use of additives belonging to the groups of antibiotics in 
animal feeding (Aarestrup, 2003). In 1995, when Sweden accessed as a member of the 
European Union, it was authorized to keep in force its legislation on feed additives 
before accession, until 1998. However, Sweden submitted applications, accompanied by 
detailed scientific grounds, asking for regulation for the antibiotics authorized in the 
Community. 
Following the ban on all growth-promoting antibiotics in Sweden, other member states 
prohibited on their territories the use of some AGP. The driving forces behind the 
national bans were consumer and political opinions, and a scientific concern that 
antibiotic resistance selected in animals might be transmitted to humans (Casewell et 
al., 2003) 
As results of this national initiatives, and in spite of negative opinion of the Scientific 
Committee of Animal Nutrition (SCAN), the European Union banned the use of 
avoparcin in 1997; the four remaining antibiotics (bacitracin, spiramycin and tylosin, 
and virginiamycin) used for growth promotion were banned in 1999, on the basis of the 
Precautionary Principle (Casewell et al., 2003).  
In 1997, the World Health Organization published a report on the medical impact of the 
use of antibiotics as growth promoters in food animals, suggesting a link between the 
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 two on an epidemiological basis and advised the national governments to establish a 
surveillance of the antimicrobial usage and that animal health management should be 
routinely practiced to avoid the prophylactic use of antibiotics (Dibner and Richards, 
2005). 
Regulation 1831/2003 of the European Parliament established the European ban of AGP 
since 1st January 2006, while anticoccidial substances, such as antibiotics ionophores, 
will be banned as feed additives before 2013. After this date, medical substances in 
animal feeds are limited to therapeutic use by veterinary prescription.  
 
 
European ban on AGP: consequences on animal welfare 
 
The Nordic Countries experience had anticipated that the antimicrobials bans might 
have adverse consequences on animal health and welfare, and economic consequences 
for farmers. The most common consequences reported were increased diarrhoea in 
young piglets, higher incidence of necrotic enteritis in poultry, increased coccidiosis and 
metabolic disorders in cattle (Pradella, 2006).  
New nutritional strategies and adoption of breeding management focused on disease 
prevention, together with therapeutic treatments using antibiotics with broad spectrum 
of activity, which belonged to the same classes of antibiotics used in human and animal 
medicine, were fundamental in counteracting the spread of infectious disease in food 
animals (Wierup, 2001; Wegener, 2003; Grave et al., 2006).  
While in slaughter pig production no negative clinical or economic effects were 
observed, and the growing rate was at least as good as in Countries using 
antimicrobials, most serious consequences were observed in piglet production where 
significant problems due to increased incidence of intestinal and respiratory infections, 
particularly at the weaning. The higher incidence of infectious disease often required 
antibiotic-medicated feed at therapeutic dosage before prophylactic actions could 
decrease the use (Wierup, 2001). This unexpected occurrence evidenced that 
antimicrobial growth promoters also had a previously unrecognized health promoting 
and disease-preventing effects.  
Wierup (2001) reported that the use of antibiotic therapies in Sweden increased during 
the following 4-year after the ban, involving up to 75% of the pigs. Nonetheless, the 
overall use of antimicrobials in food animals was reduced: it decreased of 55% in the 
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 13-years after the antimicrobials withdrawal. However, the production losses in 
Swedish pig husbandry were non fully recovered 20 years after the ban (Casewell, 
2003; Wierup, 2001). 
Afterwards, the withdrawal of antibiotics caused a transient impairment of animal 
welfare and despite the efforts to improve other aspects of husbandry, the veterinary use 
of therapeutic antibiotics, identical to those used in human medicine, has increased, and 
this constitutes a hypothetical hazard to human health in relation to resistance in 
Salmonellae spp, Campylobacters and zoonotic strains of E. coli (Casewell, 2003).  
 
 
Trends of antibiotic resistance development after AGP ban 
 
Antibiotic resistance is a natural feature of antibiotic-producing organisms as a 
protection from their own products, and of other originally susceptible organisms 
which became resistant to their competitive attack (Philips et al., 2004). Already in 
1944 Fleming found that some strains of Staphylococcus aureus developed antibiotic 
resistance and gave the first warnings (Economic and Social Committee, 98/C/ 
407/02).  
Resistance to antibiotics was first identified in human hospitalized patients, where 
penicillin-resistant Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) 
were dominant. 
Since antimicrobial resistance is an inevitable consequence of antibiotics use, a reduced 
usage should determine a progressive reduction in the acquired antibiotics resistance. 
Nonetheless, even low-level resistance can lead to a reduced antibiotic efficacy within 
the clinically susceptible range. 
The debate on the use of AGP was based on the assumption that all such use might be 
an hazard for human health since it might act as an important source of resistance genes 
in bacteria that could be transferred to human pathogens via the food chain (Phillips et 
al., 2004).  
One of the main expectations of the European AGP withdrawal was a diminished 
antibiotic resistance but, so far, the results obtained are contradictory. 
Salmonellae spp. are Gram-negatives organisms responsible for the major zoonoses in 
Europe. Tetracyclines as AGP were banned in EU in 1970 because of the appearance of 
multiresistant Salmonella typhimurium strains during the ‘60s. It seems that the ban has 
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 not achieve its objective if we consider that the percentage of tetracycline resistance in 
Salmonella spp. isolated from retail chicken in the United Kingdom (23%; Food 
Standards Agency, 2001) were found to be higher than in the United States (19%; 
NARMS, 2000), where tetracyclines are still allowed as growth promoters (Bywater, 
2005). Moreover, tetracyclines are used in Europe for disease treatment, making it 
difficult to discriminate any selection pressure resulting from the former growth 
promotion use as opposed to therapeutic one (Bywater, 2005). 
In Europe, after the avoparcin ban, reduced carriage of vancomycin resistance in 
enterococci (VRE) in animal and human faeces was reported (van den Bogaard, 1998; 
Klare et al., 1999; DANMAP, 2003). On the contrary, in the US the VRE incidence was 
found higher despite the fact that avoparcin has never been used there in food animals 
(CDC 1999). 
A recent European survey on antimicrobial susceptibility among zoonotic and 
commensal bacteria in food producing animals has shown a very low presence of 
resistance towards drugs used in humans. Indeed, some VRE was detected but in a very 
low number (de Jong et al., 2009). 
The prevalence of Salmonellae in Europe after the ban decreased and the few cases of 
human infection are related to consume of imported products and travellers (Aarestrup 
and Pires, 2009). 
In the meantime, the pattern development of resistance among human pathogens has not 
changed, being more correlated with antimicrobial use in human hospitals, general 
practice, incorrect waste disposal, than to veterinary use. 
 
 
Economic and environmental implications 
 
Post weaning period in pig production has been the most critical phase during which are 
experimented the detrimental effects caused by the elimination of AGP (Göransson, 
1997, Lallès et al., 2007). Lallès et al. (2004) reported that the mortality of piglets in 
Europe amounted to 17% of the all pig born and great part of this loss was due to 
infectious diseases. 
The ban of AGP had an economic impact on farms, due to increased costs for veterinary 
prescription and therapies, lost of feed use efficiency, prolongation of the production 
cycle. 
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 It was reported that in Sweden the time necessary to reach 25 kg of piglet live weight 
increased of 5.2 days and the production costs increased of 1-3 $ head (Robertsson, 
1994; Kjeldsen, 2005; Jensen, 2006).  
Estimates of the financial impact of antimicrobial withdrawal in United States on 
consumers were evaluated to be in a range between 5 and 40 $ per capita per annum 
(NRC, 1999; Mathews, 2001). 
By improvement of feed conversion, AGPs had a favourable effect on manure 
production: less feed was required to achieve a given amount of growth in an animal, as 
a result of which nitrogen and phosphate excretion was reduced in proportion to manure 
production (Gropp and Schumacher, 1997; Roth and Kirchgesser, 1993). Thus, the 
termination of AGP use could cause an increased N and P excretion.  
Moreover, decreased feed efficiency is likely to cause an increased demand for 
cropland, with consequences on the land prices and a possible increased grazing 
pressure in fragile landscape (Phillips et al., 2004; Montesissa and Calini, 2006).  
 
 
Weaning piglets without AGPs: what a stress! 
 
Producing pigs without the use of in feed antimicrobials is a great challenge for the 
European swine industry, especially at the weaning.  
Weaning is a critical period for all mammalians and particularly for piglets in intensive 
production systems where, in order to maximize the annual sow production, the 
suckling period has been reduced from 5-6 to 3-4 weeks of age. The employ of AGPs 
has been strategic in reducing the effects of premature weaning on piglets health and 
growth performance. Indeed, early weaning practices expose piglets to nutritional, 
social and environmental stresses when the immune and the gastrointestinal systems 
have not completely reached the functional development (Partanen and Mroz, 1999).  
Several stresses take place at the same moment: switch from liquid and highly digestible 
milk-based diet to a less digestible more complex cereal-based dry feed, separation from 
the sow, mixing of the litters, change of the environment (Hiss and Sauerwein, 2003). 
This situation often results in low voluntary feed intake, severe growth check and lead 
to an impaired health status and to a major susceptibility towards infections and gut 
disorders (Lallès et al., 2004, 2007, 2009). Indeed, weaned piglets frequently show 
malabsorption syndrome, characterized by increased excretion of carbohydrates and 
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 fatty acids in faeces, watery stools and degeneration of the intestinal epithelium. 
Opportunistic pathogens such as enterotoxigenic E. coli can take advantage from the 
poor health condition of piglets causing the post weaning diarrhoea syndrome (PWDS) 
(Kyriakis, 1989). 
Recent review articles have focused on morphological and functional changes (Pluske, 
2001), physiological changes (Lallès et al., 2004), host-microbe interactions (Gaskins, 
2003) and on the effects of dietary ingredients on the gut integrity and performance in 
weaned pigs (Vente-Spreeuwenberg and Beynen, 2003; Verdonk et al., 2005; Lallès et 
al., 2007; Lallès et al., 2009). 
Stress may be an initiating factor for weaning-associated alterations in the 
gastrointestinal tract resulting in altered gastric motility and emptying, mucus secretion, 
permeability and water absorption (Fieramonti, 2003). At least the increase in intestinal 
permeability involves the hypothalamo-pituitary-adrenal axis and endogenous 
glucocorticoids. Acute and chronic stressors, alone or in combination with starvation, 
have been shown to induce intestinal mucosal damage and increased permeability in 
rats (Saunders et al., 1994; Spitz et al., 1996; Kiliaan et al., 1998; Bagchi et al., 1999; 
Wirén et al., 1999; Santos et al., 2000; Saunders et al., 2002). 
Moeser et al. (2006) investigated the effect of weaning-associated stresses on piglets 
gastrointestinal health and found that corticotrophin release factor (CRF) and cortisol 
level in serum during increased during the first week after weaning. The higher CRF 
level was associated to an injury of the intestinal barrier function, evidenced by reduced 
jejunal and colonic transepithelial electrical resistance (TEER) and increased short 
circuit current (Isc) measured in vitro. Furthermore, the blockade of the CRF receptors 
prevented the intestinal disturbances (Moeser et al., 2006).  
The intestinal epithelium is composed by a single layer of columnar cells and it is the 
organism’s first line of defence against harmful microorganisms and antigens within the 
intestinal lumen (Gewirtz et al., 2002). It appears that the activation of the central stress 
pathways is the main cause of the alterations of the intestinal mucosal physiology, as the 
increased secretion and barrier disruption observed at weaning. The intestinal barrier 
break-down leads to increased intestinal permeability to diet antigens, bacteria and 
toxins, resulting in mucosal inflammation and release of cytokines and chemokines. 
Mc Cracken et al. (2001) found a transient increase of IL-1 concentration in piglets 
blood during the first 2 days post weaning. Piè et al. (2004) demonstrated that weaning 
is associated to a transient up-regulation of intestinal expression of pro-inflammatory 
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 cytokines IL-1β, IL-6 and TNF-α, that varied in the different regions of the gut. The 
over expression of pro-inflammatory cytokines mRNA was rapidly down-regulated 
within 2d post weaning, likely to avoid the tissue damage with the exception of TNF-α, 
which remained high in both ileum and colon. The pro-inflammatory cytokines release 
leads to modifications of the intestinal physiology, mainly affecting the permeability 
capacities of the intestinal mucosa, the enzymes activity, and it determines loss of 
appetite and stimulation of general catabolic activity. When stimulated by enteric 
pathogens, intestinal epithelial cells release a range of inflammatory mediators other 
than cytokines, such as cyclooxygenase (COX) 2 and nitric oxide (NO) and reactive 
oxygen species (ROS) (Verdonk, 2005). Reactive oxygen species and nitric oxide are 
known to play a double role in biological systems, since they can be either harmful or 
beneficial to the organism (Valko et al., 2006). Expression of cyclooxygenase (COX) 2 
and increased production of prostaglandin E2 in intestinal epithelial cells leads to 
increased chloride secretion (Eckmann and Kagnoff, 2005).  
Feed intake determines performance and gut morphology in weaned pigs (Pluske et al., 
1997; Spreeuwenberg, 2002). It was estimated that at weaning only 50% of piglets 
consume their meal within 24h and it take 3 days to meet the requirement of energy and 
food intake for maintenance (Le Dividich and Sève, 2000). The dramatic reduction of 
nutrient intake and the diet changes lead to adverse alterations of intestinal morphology, 
including villous atrophy and crypt hyperplasia (Pluske et al., 1997) caused by an 
increased rate of cell loss and a decreased rate of cell renewal, reduced absorptive 
capacity and brush border enzyme activity (Hampson 1986, Kelly et al., 1991a and 
1991b; Miller et al., 1984a,). The increased rate of cell loss is likely due to apoptosis or 
programmed cell death. Under normal conditions apoptosis of differentiated enterocytes 
on the villous is rare but it increases in response to pathological and stressful conditions 
such as lack of luminal nutrition (Fukuyama et al., 2001).  
The weaning process, characterized by a shift of the diet, feed restriction and stress, 
leads to instability of the intestinal microflora, with reduction of the lactic acid bacteria 
community (Kostantinov et al., 2003, Lallès et al., 2007). At birth the gut is colonised 
by microorganisms deriving from the mother and the environment, starting from lactic 
acid bacteria, enterobacteria and streptococci. The intestinal microflora is a complex 
and dynamic ecosystem which interact with the host. Intestinal microbiota is considered 
an essential for the development of the animal immune system and physiology (Hooper, 
2006). Epithelial cells recognize the colonising bacteria by the virtue of cell-surface 
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 pattern of recognition receptors such as Toll-like receptors (TLR) (Kelly, 2001). The 
development of the intestinal microbiota communities is affected by the diet 
components and changes in the amount of nutrients available for microflora 
fermentation determines the type and the metabolic activity of the intestinal microflora.  
 
 
Looking for an alternative 
 
The 1999 partial ban of antibiotics as in-feed additives has awakened the interest for 
feed additives and led to intensive research for valid alternatives to AGP, able to 
counteract health problems in farm animals, and particularly in weaned piglets. Indeed, 
AGP were more effective in young animals such as in piglets after weaning, specially 
raised in poor sanitary conditions (Anderson et al., 1999). 
So far, various nutritional approaches aimed to the optimization of the weaning 
transition and reduction of the GIT disease have been proposed, but the success rates 
were really low compared to antimicrobials (Lallès et al., 2009). 
According to Niewold (2007), the search for effective alternatives is hampered by a lack 
of knowledge about the mechanisms of the antibiotics-mediated growth enhancement. 
In-feed antibiotic growth promoters have been considered for a long time as acting 
essentially on the gut microbiota, by decreasing the potentially harmful effects of 
pathogenic bacteria (Dibner and Richards, 2005). The major theories proposed to 
explain the mechanism of action of the AGP recognize in the intestinal microflora the 
main target: 
 
 AGP inhibited endemic subclinical infections, thereby reducing the energy cost 
of the innate immune system; 
 the use of AGP resulted in a decrease in bacterial population, therefore lowering 
the accumulation growth-depressing metabolites production by intestinal;  
 AGP reduced microbial use of nutrients; 
 AGP improved the ingestion and use of nutrients due to a thinner of the 
intestinal wall. 
 
All these theories share the hypothesis that the intestinal microflora reduces, either 
directly or indirectly, the animals growth and that the AGP-mediated growth 
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 enhancement is due to the antimicrobic properties of these molecules. The limitations 
and contradiction of these theories were reviewed and analyzed by Niewold (2007), 
who suggested an anti-inflammatory role of the AGPs. According to the author, it is 
unlikely that antibiotics, administrated at doses lower than minimum inhibitory 
concentration (sub-MIC), might have an inhibitory effect on the intestinal pathogens or 
a modulate the selection of a “good microflora” (Niewold, 2007). Moreover, the chronic 
use of antibiotics should have led resistance in the target microorganisms and thus 
affected their efficacy. As remarked by Gaskins (2002), the use of probiotics as growth 
promoters is a paradox, since the gut microbiota is supposed to produce growth 
depressing metabolites such as ammonia and bile degradation products. It is also 
curious that AGP had similar growth promoting effects on animals of different species 
and at different stage of development, which undoubtedly have a different gut 
microflora (Niewold, 2007).  
Stress conditions, as transport or weaning, were demonstrated to enhance the 
inflammatory state of the intestinal mucosa and its permeability (Mc Cracken et al., 
1999; Niewold, 2000; Bailey et al., 2005). Permeability of the intestinal epithelium to 
macromolecules is increased in presence of inflammatory conditions as in the gut 
mucosa, which is considered an organ in a state of constant and controlled inflammation 
(MacDonald and Monteleone, 2005). A side effect of the antibiotic molecules is that 
they can accumulate inside the inflammatory cells, enhancing the destruction of 
intracellular pathogens (Labro, 2000; Niewold, 2007). The accumulation of antibiotics 
within the phagocytes leads to down regulation of the innate immune response with a 
sensitive reduction of the production of pro-inflammatory cytokines that results in lower 
catabolic stimulus (Schoevers et al., 1999; Labro 2000, Niewold 2007). Furthermore, 
they can inhibit or decrease the innate immune response such as production of reactive 
oxygen metabolite and pro-inflammatory cytokines by macrophages. According to 
Niewold (2007), the energy saved by the down regulation of the immune response (due 
to the anti-inflammatory effect of AGP) is thus available for the enhancement of the 
animal growth. This theory suggested that the inhibitory/modulator effects observed on 
the microflora of animals fed AGPs are secondary ones, likely due to a healthier 
intestinal mucosa (Niewold, 2007). Therefore, the alternatives to in-feed antibiotics 
useful should be substances capable to down regulate the inflammatory response at the 
intestinal mucosa level, which is a physiological effect of weaning.  
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 Spray dried plasma (SDP)  
SDP is a by-product obtained from animal blood after exclusion of cells, concentration 
and spray drying. Three types of SDP products, from porcine (SDPP), bovine (SDBP) 
and unknown or mixed animal origin (SDAP) are available commercially (Lallès et al., 
2009). Feeding SDP was temporary banned in Europe as a consequence of the bovine 
spongiform encephalopathy crisis, but is now allowed for pigs. Hygienic collection and 
processing of the blood are essential to avoid the transmission of infectious disease 
(DeRouchey et al., 2004; van Dijk et al., 2001).  
It was reported that SDP has beneficial effects on weaning piglets weight daily gain, 
feed intake and feed efficiency (Coffey and Cromwell, 2001; van Dijk, 2001; Moretò 
and Pèrez-Bosque, 2009). In an epidemiological study of Canadian swine farms, 
feeding SDP was associated with reduced mortality due to porcine reproductive and 
respiratory syndrome and porcine circovirus type 2 (Dewey et al., 2006). 
The origin of the plasma has great influence on the growth promoting properties of 
SDP, porcine plasma was reported to be more effective (Owusu-Asiedu et al., 2002). 
Reduced extent and severity of diarrhoea, decreased ETEC shedding by feeding SDPP 
to piglets challenged with pathogens was reported (Owusu-Asiedu et al., 2003).Dietary 
inclusion of SDPP (6%) improved ADG and ADFI during the first 10 d after weaning 
while no significant effect were seen on G:F rate and on intestinal morphology (Zhao et 
al., 2007). 
Improved feed intake, due to high palatability of the diet and high digestibility of the 
protein, was considered the major contributing factor for the enhanced growth in 
animals fed SDP. Actually, since SDP contains from 15 to 20% of immunoglobulin, 
great part of the beneficial effects observed on growth performance are related to its 
immunological properties (Thomson, 1994; Pierce, 2005; Lallès et al., 2007 and 2009). 
SDP was reported to lower pro-inflammatory cytokine expression in many organs and 
to decrease the immune cell density in the intestinal mucosa (Touchette et al., 2002, 
Jiang et al., 2000, Bosi et al., 2004, Moretó et al., 2008). SDPP fed to early-weaned 
piglets challenged with ETEC K88 enhanced growth performance, decreased intestinal 
mucosal damage and inflammation, reduced IgA anti-K88 secretion and pro-
inflammatory cytokine expression in the gut (Bosi et al., 2004). 
Porcine plasma was found to contain specific E. coli F18 antibodies, and when tested in 
E. coli F18-challenged piglets, it improved growth and feed intake (Owusu-Asiedu et 
al., 2002). In contrast, other studies on piglets fed a plasma source without specific 
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 immunoglobulin against E. coli F18 showed that SDP impedes E. coli F18 binding to 
the enterocytes by receptor competition through a non-specific protection mechanism 
(Nollet et al., 1999). SDP from pigs vaccinated against specific pathogens resulted in 
modest production advantages, compared to conventional SDPP, in piglets challenged 
with the same pathogen (Niewold et al., 2007). This could suggest that non-specific 
mechanisms might play a role or that pre-existing antibodies might already be present in 
conventional SDPP as a consequence of ‘natural’ challenge (Lallès et al., 2009). 
The enhancement of growth performance is mainly attributed to the reduced 
inflammatory response in the intestine and to the maintenance of mucosal integrity that 
limited the pathogen colonization, due to its immunoglobulin fraction (Bosi et al., 2004; 
Lallès et al., 2009). The mechanisms by which SDP might counteract pathogen 
infectivity may include improvement of immunocompetence or reduction of pathogen 
adhesion to the mucosa by the immunoglobulins and glycoproteins present in plasma 
(Sanchez et al., 1993; Van Dijk et al.2001).  
Spray-dried plasma appears to have good characteristics to be a valid alternative to 
AGP: it reduces the overstimulation of the immune response allowing more of the 
available energy and nutrients to be used for growth and other productive functions 
rather than being diverted to support the immune response (Moretò and Perez-Bosque, 
2009).  
 
 
Organic acids 
Potential alternative to antibiotic growth promoters are certainly organic acid and their 
salts. Organic acids were traditionally used as food preservatives to prevent, through pH 
depression, microbial contamination of raw materials (Partanen and Mroz, 1999; Canibe 
et al., 2005). The antimicrobial activity of organic acids is due to their ability to change 
from undissociated to dissociated form, depending on the environmental pH. 
Undissociated acid can freely diffuse through the membrane of microorganisms into 
their cell cytoplasm, where the acid dissociation, due to the neutral pH, leads to a 
suppression of cell enzymes (decarboxylases and catalases) and nutrient transport 
systems (Lueck 1980). The efficacy of an acid in inhibiting microbes depends on its 
pKa value, which is the pH at which 50% of the acid is dissociated. Organic acids with 
higher pKa values are more effective preservatives and their antimicrobial efficacy is 
generally improved with increasing chain length and degree of unsaturation (Foegeding 
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 and Busta, 1991). Limited digestive and absorptive capacity due to inadequate HCl 
production, insufficient pancreatic and intestinal enzymes activities, sudden changes in 
feed consistency and intake are involved in the post weaning gut disorders (Aumaître et 
al., 1995; Cranwell, 1995). The stomach pH plays an important role in limiting the entry 
of bacteria into the gut. Furthermore, low gastric pH reduces the gastric emptying rate, 
allowing more time for protein hydrolysis in the stomach (Mayer, 1994). Lowering 
dietary pH by weak organic acids, such as benzoic, formic, fumaric, lactic, propionic, 
butyric acid and their salts was reported to improve growth performance, reducing 
intraluminal concentration of coliform bacteria and diarrhoea incidence in piglets 
(Partanen and Mroz, 1999; Canibe et al., 2005; Lallès et al., 2009). However, it was 
reported great variability on piglets growth performance response to organic acids, 
likely related to the type and dose used (Partanen and Mroz, 1999, Lallès et al., 2009). 
A combination of 1% lactic acid and 1% formic acid added to a piglet’s diet reduced 
gastric pH and the concentration of lactic acid bacteria and enterobacteria (Hansen et 
al., 2007). Inclusion of 1.8% of K-diformate to a piglets starter diet had no effect on 
growth parameters and on gastric and intestinal pH, meanwhile a decrease of total 
anaerobic bacteria, lactic bacteria and coliforms was found in digesta and faeces 
(Canibe et al., 2001). The efficacy of 6 organic acids in counteracting post-weaning 
diarrhoea syndrome was evaluated by Tsyloyannins et al.(2001), who found improved 
growth performance, reduced diarrhoea severity and K88 E. coli excretion in faeces, 
though mortality rate was not affected. Free Ca-formate supplementation in weaning 
diet fed to ETEC-challenged piglets improved post-challenge growth, feed intake, gain 
to feed ratio, reduced the days of diarrhoea and faecal excretion of total (but not K88-
specific) E. coli and increased villous height in the small intestine (Bosi et al., 2007). 
Torrallardona et al. (2007b) found that Ca-formate, fed to piglets challenged with E. 
coli K99, did not improve neither growth performance nor total E. coli count in ileum, 
but jejunal villous height was reduced.  
Reduced feed intake of organic acid supplemented diets was reported (Eisemann and 
van Heugten, 2007). Microencapsulation is an important tool to improve acidified diets 
consumption, to avoid gastric absorption of organic acids, delivering them to the small 
intestine where they can exert the antimicrobial activity. A great advantage of this 
technique is to reduce the amount of acid use (Piva et al. 2007). 
The beneficial effects of butyrate and its precursors on colon mucosa morphology were 
reviewed by Hammer et al. (2008). Sodium butyrate (SB) included (0.3%)  to a starter 
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 diet, fed to piglets for 2 weeks after weaning, improved feed to gain ratio, increased 
gastric dry matter percentage and induced large changes in microbial community 
composition of caecum and distal colon, depressing amilolytic bacteria growth (Castillo 
et al., 2006; Manzanilla et al., 2006). 
Combined supplementation of tributyrin and lactitol to piglets diets increased growth 
performance and villous height in the jejunum, reduced histamine levels in jejunal and 
caecal tissues and caecal crypt depth (Piva et al., 2002). Tributyrin alone had adverse 
effects on growth performance, with no influence on jejunal villus height, even if it 
reduced drastically caecal crypts depth; lactitol alone stimulated jejunal villous height 
and lactic acid level in the caecum while reducing caecal crypt depth (Piva et al., 2002).  
However, the results obtained so far with oral supplementation of SB or its precursors, 
indicate that the outcomes are influenced by various factors such as dose, 
supplementation length, site of observation and age of the animals (Lallès et al., 2009). 
 
Phytogenic feed additives 
Essential oils and oleoresins are claimed to exert antioxidative, antimicrobial and 
growth-promoting effects in farm animals (Windish et al. 2008). The mechanism of 
action of essential oils has not been clearly identified but it appears that the 
antimicrobial activity is related to changes in lipid solubility of bacteria cell wall (Stein, 
2006). Essential oils appear to act synergistically with organic acids (Burt, 2004; 
Manzanilla et al., 2009; van Dijk et al., 2009). 
Michiels et al. (2007) assayed the effects of thymol, eugenol, carvacrol and trans-
cinnemaldehyde, alone or in combination, in in vitro simulations of the fermentation in 
the GIT. Trans-cinnemaldehyde was found to be the most successful against coliform 
bacteria, even at low doses, while carvacrol and thymol showed to have broad spectrum 
of activity and to act synergistically by reducing the lactobacilli population, whose 
development was not inhibited by trans-cinnemaldehyde. Si et al. (2006) demonstrated 
the high efficacy of carvacrol, thymol and eugenol against Salmonella typhimurium 
DT104, E. coli O157:H7 and E. coli K88, while little inhibition was found towards 
beneficial lactobacilli and bifidobacteria when they were incubated with pig caecal 
digesta.  
However, data on swine evidenced a high variability of phytogenic additives on growth 
performance and intestinal morphology (Namkung et al., 2004; Demir et al., 2005; 
Jamroz et al., 2006; Nofrarias et al., 2006; Oetting et al., 2006). A mixture of carvacrol, 
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 cinnemaldehyde and Capsicum oleoresin, given at increasing doses to weaned piglets, 
reduced diarrhoea incidence, increased the intestinal lactobacilli and improved the 
lactobacilli/enterococci rate, while no significative influence was observed on growth 
parameters (Manzanilla et al., 2004, Castillo et al., 2006, Nofrarias et al., 2006). Walter 
and Bilkei (2004) reported beneficial effects of carvacrol (180 ppm) on piglets weight 
daily gain and feed conversion rate. Furthermore, the percentage of CD4+, CD8+and 
MHC-II+ was increased in peripheral blood after carvacrol feeding. These findings 
suggested a regulatory role of essential oils in the immune response. 
In vitro studies revealed that carvacrol can protect human lymphocytes and other cells 
from oxidative stress, even if it is cytotossic at high concentration (Aydin et al., 2005; 
Horvathova et al., 2006). Treatment of porcine intestinal epithelial cells (IPEC-1) with 
>5 mM of carvacrol caused disruption of the epithelial barrier function (Roselli et al., 
2007). Bimczok et al. (2008) reported a reduced in vitro pig lymphocyte proliferation 
after exposure to carvacrol, likely due to apoptosis. Manzanilla et al. (2006, 2009) and 
Nofrarias et al. (2006) found a diminished number of intraepithelial lymphocytes in the 
jejunum of pigs fed a diet containing phytogenic feed additives.  
According to Michiels et al. (2008), the absence or the reduction of the antimicrobial 
properties of essential oils in in vivo trials might be due to the low doses used and to the 
early absorption in the upper part of the GIT. Moreover, diet composition, including fat, 
protein, carbohydrates and water play a key role in the antimicrobial activity of essential 
oils (Si et al., 2006, Manzanilla, 2009). 
 
Prebiotics and Probiotics  
A probiotic is defined a non-pathogen microorganism able to colonize the gut and 
prevent the outbreak of intestinal disorder. According to Gibson et al. (2004), a 
prebiotic is “a selectively fermented ingredient that allows specific changes both in the 
composition and/or activity in the gastrointestinal microflora that confers benefits upon 
host wellbeing and health”. Inclusion of fermentable carbohydrates and/or probiotics to 
the diet of weaning piglets is a way to improve the microbial balance in both the small 
and large intestines (Williams et al., 2001; Bauer et al., 2006). The addition of sugar 
beet pulp, inulin, lactulose and wheat starch, was found to significantly affect 
microflora composition in the gastrointestinal tract of piglets (Konstantinov et al., 
2004a). As reported by Konstantinov et al. (2004a, 2006a), inclusion of fermentable 
carbohydrates in the diet could enhance colonic microbial stability and diversity, while 
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 stimulating the growth of Lactobacillus sobrius, a beneficial member of the porcine 
commensal microbiota. Using chaperonin-60 gene clone libraries, it was shown that L. 
amylovorus-related populations, likely L. sobrius, are highly abundant in the ileum of 
weaned piglets fed either corn–barley or wheat-based diets, even if with high individual 
variation (Hill et al., 2005). Loh et al. (2006) found that the inclusion of inulin to 
different basal diets significantly affected the proportion of piglets with detectable 
levels of bifidobacteria, while the lactobacilli population was not affected. 
After weaning, since the lactase activity is reduced, lactose can act as prebiotic for 
microbial fermentation. High lactose level in weaner diets improved bifidobacteria and 
lactobacilli populations while decreasing E. coli, increased volatile fatty acids (VFA) 
and butyric acid and reduced branched VFA (Pierce et al., 2006, 2007). However, the 
beneficial effects of lactose are influenced by the diet protein level and inulin 
supplementation.  
Van Nevel et al. (2005) found that the addition of galactomannans to piglets diet caused 
decreased numbers of lactobacilli in stomach and jejunum feeding guar gum, while 
carob tree seeds increased E. coli counts in distal jejunum and in jejunal mucosa. 
Fructo-oligosaccharides (FOS) are oligosaccharides, mainly of plant origin, that have 
been shown to resist to endogenous glycolytic enzymes of the host and to arrive 
unaltered to the colon (Oku et al., 1984). FOS can significantly modulate the colonic 
microbiota by increasing the number of specific bacteria and thus changing the 
composition of the microbiota. With the combination of an oligosaccharide and a 
probiotic, the benefits include improved survival of the probiotic bacteria during 
passage through the upper intestine and a more efficient colonization in the colon, 
together with a stimulating effect of the oligosaccharide on growth and activities of both 
the probiotic and endogenous bacteria (Roberfroid, 1998). 
At weaning, the attitude of bacteria to produce a range of compounds is useful to inhibit 
the pathogenic bacteria growth through the competitive exclusion (Diez-Gonzalez, 
2007). Probiotics are claimed to enhance the population of beneficial microorganisms, 
by enhancing microbial enzyme activity and by improving diet digestibility and 
nutrients utilisation (Burgstaller et al., 1984). Probiotics can positively affect gut 
microbiota balance, intestinal epithelium integrity, proper maturation of the gut 
associated tissue and the neuro-endocrine system function (Metzler et al., 2005). A mix 
of four lactobacilli isolated from weaning pigs decreased diarrhoea, E. coli presence and 
anaerobes counts in the gut (Huang et al., 2004). Dietary supplementation of L. sobrius 
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 strain 001T to a diet based on fermentable fibre improved the body weight gain of 
weaned pigs orally challenged with ETEC K88, reduced ileal ETEC, but it had not 
effects on diarrhoea severity (Konstantinov et al., 2005). 
Supplementation with Lactobacillus rhamnosus GG, a “human” well-known probiotic, 
to weaning piglets challenged with ETEC, resulted in reduced growth and a trend to 
more ETEC excretion in faeces was observed (Trevisi, 2005). An interesting study on 
the interactions between intestinal physiology, diet supplementation with the probiotic 
E. coli strain Nissle 1917 and ETEC challenge has been conducted by Schroeder et al. 
(2006). Piglets were creep-fed during the suckling period, with a diet supplemented (or 
not) with E. coli strain Nissle 1917 for 10 d, starting from d 7 of age, weaned at 21 d of 
age and challenged with ETEC at 4 and 24 h post weaning. The probiotic used 
abolished diarrhoea, reduced jejunal secretagogue-induced chloride secretion and, 
compared to the non supplemented piglets, suppressed the decreased paracellular 
permeability usually seen after ETEC challenge (Schroeder et al., 2006). High doses of 
E. coli strain Nissle 1917 increased the density of CD8+ cells in the ascending colon 
while at low dosage there were no influence on the number and neither distribution of 
intestinal immune cells nor that of antimicrobial peptides (Duncker et al., 2006). 
Supplementation of piglets with Enterococcus faecium tended to decrease serum IgG 
levels after 20 d of treatment (Broom et al., 2006). Interestingly, supplementing the 
sows with E. faecium strongly decreased the incidence of diarrhoea in piglets the first 
week post weaning (Taras et al., 2006). It reduced the level of cytotoxic (CD8+) T-cells 
in the jejunal epithelium of their piglets, probably in relation with the lower frequency 
of β-haemolytic and O141 serovars of E. coli (Scharek et al., 2005).  
Many mechanisms are involved in the probiotics-mediated intestinal epithelial cell 
protection against ETEC, including competitive exclusion, reduced ETEC adhesion, 
maintenance of epithelial tight junction integrity, reduced neutrophil transmigration and 
increased mucin gene expression, with great variability depending on the probiotic 
strain used (Roselli et al., 2005a). 
However, it is noteworthy that the data concerning the efficacy of probiotics are often 
contradictory and that bacteria strains that were supposed to be host competitor for 
nutrients are used as animal growth promoters.  
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 Amino acids  
Peptides and proteins are major constituents of body tissues. Several essential and non-
essential amino acids are considered to have therapeutic effects on the GIT and on the 
whole organism (Kim et al., 2007). Specific amino acids can promote health by 
improving (gut) tissue anabolism, by reducing the impact of stress and by modulating 
local immunology (Lallès et al., 2009). Experimental results of administration of amino 
acids with biological activity to diseased animals suggested that the immune system 
requires a specific amino acid profile, different from that for growth (Reeds et al. 1994). 
From literature, the amino acids that proved to affect physiology, immunology and 
metabolism of the animals are glutamine, tryptophan, arginine, cysteine and threonine 
(Lallès et al. 2009). Glutamine and glutamate are known to be a major energy source for 
intestinal epithelial cells and, when added to weaner diets, preserved the enterocytes 
turnover rate, due to improved mitotic processes and decreased apoptosis that resulted 
in higher villi (Domeneghini et al., 2004, 2006). Glutamine was proved to stimulate the 
innate and the adaptive immune system in early weaned piglet, as shown by increased 
densities of macrophages and lymphocytes in the ileal mucosa (Domeneghini et al., 
2004). Glutamine supplementation resulted in lower blood cortisol on the first day after 
weaning (Zhou et al., 2006). Koopmans et al. (2006) found that tryptophan reduced the 
weaning-associated damage of the intestinal mucosa, reduced blood cortisol and 
noradrenaline levels and preserved growth in weaned piglets submitted to immune 
stress. A standard weaning diet supplemented with 100 mg/kg L-tryptophan improved 
daily weight gain and feed intake of piglets during the first 4 days after E. coli K88 
challenge (Trevisi et al., 2008).  
Alanine and glycine have been shown to stimulate the production of the so-called 
antisecretory factor protein (AF), improved growth performance and reduced the 
incidence of diarrhoea (Göransson et al., 1993; Göransson, 1997). Cereals kernels 
submitted to a patented hydrothermal process were to stimulate the AF endogenous 
secretion and improve animals growth performance (Lange and Lönnroth, 2001). 
The AF protein, derived from different sources, inhibited intestinal fluid secretion and 
inflammation in enterotoxin-challenged rat and pig intestinal loops (Lange and 
Lönnroth, 2001). The antisecretory factor is present in sows’ colostrum and milk is 
transferred from the sow to the foetus across the placenta (Sigfridsson et al., 1995). 
According to Lönnroth et al. (1988), there is a correlation between AF content in milk, 
its level in piglet’s blood and incidence of diarrhoea in the litter, it was hypothesised 
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 that AF could be a protection factor against diarrhoea in suckling piglets. In piglets 
plasma, AF activity has a cyclic variation and is sensitive to stress: at the weaning it 
declines, reaching the lowest level the third day after weaning (Lönnroth and Lange, 
1988; Lange et al., 1993). The onset of diarrheal disease is significantly correlated with 
the low plasma AF activity (Lange and Lönnroth, 2001). 
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 Antisecretory factor as a potential health-promoting 
molecule in humans and animals 
 
Abstract 
The antisecretory factor (AF) is a protein secreted in plasma and other tissue fluids in 
mammalians with proved antisecretory and anti-inflammatory activity, its 
immunohistological distribution suggests a role in the immune system. The expression 
level and the distribution of AF protein are altered during an immunological response. 
Exposure to bacterial toxins induces secretion of AF in plasma, probably reflecting a 
natural defence mechanism to agents causing diarrhoea, thereby contributing to a 
favourable clinical outcome and disease termination. Increase of AF level in plasma by 
dietary means, such as hydro-thermally processed cereals (HPC), has been 
demonstrated in human and animals.  Administration of HPC to patients affected by 
inflammatory bowel disease, gastroenteritis and Ménière’s disease relieved symptoms 
and improved quality of life. A recent study showed the positive effect of HPC diet 
supplementation on prevention of the effects of exposure to low levels of blast 
overpressure in rats, reducing the extent of intracranial pressure increase and cognitive 
function impairment. AF-rich egg yolk powder improved health status in children 
suffering acute and chronic diarrhoea, reducing the frequency and increasing the 
consistency of stools. This kind of functional food could be used for prophylaxis in 
populations exposed to a high risk of morbidity and mortality caused by diarrhoea and 
as a complementary therapy in patients affected by chronic intestinal inflammatory 
disease to improve well-being. In pig husbandry AF-inducing diets, owing to their 
antisecretory activity and anti-inflammatory action, are suitable option as alternative to 
antibiotic growth promoters to counteract post-weaning diarrhoea. 
 
Keywords: antisecretory factor, diarrhoea, hydrothermally processed cereals, IBS. 
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 Introduction 
 
Antisecretory factor (AF) is a 41 kDa endogenous protein which was originally purified 
in human pituitary gland by Lönnroth and co-workers (1988) and its gene has been 
cloned and sequenced. It has been established that AF is synthesized in most tissues of 
mammalians and can materialize linked to the 26 S proteasome or free in the cytoplasm 
and/or nucleus (Davidson and Hickey, 2004; Lange, 1982; Lange et al., 1999). AF was 
shown to inhibit enterotoxin-induced intestinal hyper secretion in both human and 
animal subjects. In a rat intestinal loop model, one picomole of purified AF caused a 
significant reduction of cholera toxin and E. coli toxin-induced secretion (Lange et al., 
1987). Rapallino et al. (2003) hypothesized that AF may act at the level of intestinal 
epithelial cells, by regulating the chloride homeostasis, thereby possibly counteracting 
excessive secretion of fluids in the intestinal lumen. The immunohistological 
distribution of AF suggests that this protein may play a role in the immune system as an 
anti-inflammatory agent. In rat jejunal loops, AF inhibited the inflammatory response 
caused by toxin A from Clostridium difficile (Björck et al., 2000). Intestinal exposure to 
bacterial toxins or intake of specific dietary compounds has proved to enhance the 
antisecretory and anti-inflammatory activity of endogenous AF (Johannson et al., 2008).  
Nowadays, diarrhoeal diseases remain a major global health concern, especially in the 
developing countries where the diffusion of infectious gastrointestinal pathogens is 
favoured by the poor hygienic conditions. The 4th Millennium Goal of the UN stated 
that between the years 1990 and 2015 childhood diarrhoea should be reduced by two 
thirds (United Nations, 2008). Recent reports state that childhood diarrhoea is 
responsible for 18% of all child deaths, it is estimated that 2 million children die each 
year due to excessive fluid loss, despite the introduction of oral re-hydration therapy 
(Grøndhal et al., 2002; Bryce et al., 2005). 
Not only is diarrhoeal disease a problem in developing countries, but it remains an issue 
of wealthy countries, due to a high incidence of chronic gastrointestinal diseases. 
Induction of endogenous AF through nutritional means, in addition to rehydration 
therapy and/or the pharmacological therapies, was proved to noticeably reduce fluid 
loss and bowel movements, resulting in an improvement of the patient’s well-being 
(Bjork et al., 2000; Zaman et al., 2007). A patented hydrothermal process, similar to 
malting, allows the kernels, mainly wheat and barley, to reach an optimal concentration 
of specific amino acids and oligosaccharides, able to induce endogenous AF secretion 
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 (Laurenius et al., 2003). Included in the diet of patients affected by intestinal chronic 
inflammatory diseases the hydrothermally processed cereals (HPC) improved the illness 
symptoms, reducing daily bowel movements and tissue damage (Laurenius et al., 2003). 
In livestock production, the efficacy of AF-inducing diets could be of great interest, 
especially as a tool to counteract post weaning diarrhoea syndrome in piglets. Indeed, 
wweaning is the most stressful event in piglets life, bred in intensive piggeries. Weaning 
is frequently associated with a reduced nutrient intake, severe growth check, impairment 
of the health status and to a higher susceptibility towards infections and gut disorders 
(Lallès et al., 2009; Berkeveld et al., 2009).  
For more than 50 years, the use of antimicrobial growth promoters (AGP) in animal 
diets improved growth performances and prevented the side effects of early weaning 
practice. Increasing concerns about the risk of antibiotic resistance diffusion, associated 
to the large agricultural use of antimicrobials, led the European Union to a complete ban 
of AGP since January 1st 2006. As experienced by the Nordic countries, which banned 
the AGP during the ’80s and the ‘90s, the main consequences of the elimination of AGP 
was an increased morbidity and mortality of animals, due to an increased incidence of 
infectious gastrointestinal and respiratory diseases.  
This has led to intensify the research to find alternatives to in-feed antibiotics.  
AF-inducing diets seem to be interesting alternatives to AGP and a useful tool to 
improve livestock efficiency, animal health and welfare. 
The aim of this review was to summarize the information about the antisecretory factor 
protein and its derivatives, evidencing the beneficial effects of AF-inducing diets on 
both human and animal health and welfare. 
 
 
The antisecretory factor molecule 
 
Genetics 
The AF protein was first purified in rodents extracts of the pituitary gland and intestinal 
mucosa and later in pig blood. 
AF protein is evolutionary highly conserved and it appears to be a unique protein since 
no family of AF-like proteins has been identified (Lange and Lönnroth, 2001).  
Genes coding for AF protein are present in all mammalians and homologous of AF 
genes were found only in eukaryotic organisms. In the human genome, potential AF 
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 genes are expressed in the chromosomes 1, 19 and 23, with pseudogenes located on 
chromosomes 10 and 15.   
The sequence responsible for the antisecretory activity is present only in mammalian 
proteins while in others eukaryotic organisms the proteins codified by the AF genes act 
as regulators of the proteolytic degradation in the proteasome (Lange and Lönnroth 
2001). 
AF protein from plasma is structurally different from the one obtained by the pituitary 
gland, Lange and Lönnroth (2001) showed the first is polymeric, while the second is 
monomeric. 
 
Active site  
Post translational modifications of the AF, such as proteolysis, glycosylation, 
phosphorilation, or conformational changes, could result in exposure or hiding of active 
sites, essential for the exertion of the biological activity (Jennische et al., 2003). 
Trypsin digestion of the AF protein enhanced two fold the capability to counteract the 
cholera toxin-induced intestinal secretion, indicating that in vivo AF might be activated 
by hydrolysis (Johansson et al., 1997b). The amino acids sequences derived from 
recombinant human AF trypsin digestion, were tested in a rat intestinal loop model in 
order to identify the active domain of the protein. The antisecretory activity of the 
truncated forms was related to the presence of a specific amino acid sequence between 
residues 35’ and 50’ in the N terminal part, the antisecretive potency was found to be 
dose dependent. According to Johansson et al. (1997b), the active region of mammalian 
AF is likely exerted by a small peptide of 8 amino acids (35-IVCHSKTR-42). 
Compared to the other peptides with antisecretory activity, AF appears to be the most 
potent, since somatostatin is active at nanomole and enkephalines at micromole 
concentrations, while AF is active at picomole dosages. Indeed, only 10-12 mol of AF 
are needed to revert cholera toxin-induced hypersecretion in a rat intestinal loop model.  
The smallest peptide with antisecretory and anti-inflammatory properties is the AF-16, a 
16 amino acid-long comprising the sequence VCHSK TRSNP ENNVG L, synthesized 
with solid phase technique (Johansson et al., 1997b).  
 
Receptors 
AF is present in most body tissues, it can be found in free form in the cytoplasm and/or 
nucleus or linked to the 26 S proteasome (Lange et al., 1999).  
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 Bioinformatic models suggest that the AF protein has a von Willenbrand-like motif 
(vWm) in the N terminal part, between residues 5-188, which contains the antisecretory 
sequence (Johansson et al., 2008). The vWm proteins are protein binders, Johansson et 
al. (2008) hypothesized that AF might exert its biological activities by binding to the 
receptor with its N terminal part. 
With the C terminal part, AF binds to polyubiquitin, an intracellular protein, via 2 sites 
localized between residues 211-230 and 282-301, without involving the vWm. This 
interaction is probably involved in the regulation of the proteolytic processes in the 
proteasome. 
Sections from rat brain, double labelled with antibodies against AF and flotillin-1, 
showed that there is a high degree of co-localization between AF and flotillin-1 in 
neurons and plexus choroideus (Johansson et al., 2008). Dot-blot analysis evidenced 
that AF interacts with flotillin-1 by the means of its N terminus, carrying the anti-
inflammatory and anti-secretory active site. 
The flotillin protein family is phylogenetically well preserved and consists of two 
proteins, flotillin-1 and flotillin-2 (Vassileva et al., 2008). Flotillins are ubiquitarious 
and are known to have a role in endocytosis, participate in signaling, regulation of the 
actin cytoskeleton reorganizations and actin-dependent cell adhesion and motility 
(Langhorst et al., 2005; Babuke and Tikkanen, 2007). 
Flotillin-1 is an integral membrane protein component of the lipid rafts, specialized cell 
membrane micro-domains enriched in cholesterol, sphyngolipids and gangliosides 
(Johansson et al., 2008; Allen et al., 2007; Rossy et al., 2009). In the lipid rafts there are 
proteins of key importance for cohesion and signal transduction such as receptors, 
cytoskeletal contacts and ion channel complexes (Johansson et al., 2008). 
The lipid rafts appear to play a key role in the assembly of signaling processes (Katoh et 
al., 2009) and to mediate many crucial cellular processes as endocytosis, oxidative 
stress, apoptosis, ion homeostasis and protein membrane trafficking and turnover 
(Morgan et al., 2007; Allen et al., 2007). Though lipid rafts make up a small percentage 
of the cell membrane, their high concentration of molecules involved in cellular 
signaling makes them a natural target for bacteria and viruses (Van der Goot and 
Harder, 2001). Cholera toxin attaches the intestinal epithelium by binding to ganglioside 
GM1, which is localized in the lipid rafts as flotillin-1 (Li et al., 2003). Johansson at al. 
(2008) suggested that the interaction between AF and Flotillin-1 could affect secretory 
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 processes by regulating the localization of signal proteins, such as receptors, in the lipid 
rafts.  
AF and flotillin-1 are also co-localized in the central nervous system (CNS) and their 
interaction might affect the AF modulation of glutamatergic and GABAergic synaptic 
transmissions (Johansson et al., 2008).   
 
 
Role of AF in the immune system 
 
In situ hybridization and immunohistochemical analysis demonstrated that AF is 
expressed in various mammalian organs (Lange et al., 1999).  
Monoclonal TLD antibodies, obtained from rats immunized with cultured microglial 
cells, were screened by Davidson and Hickey (2004a) with the aim to investigate the 
roles of perivascular and microglia cells in the inflammatory processes in the CNS. 
TLD-1A8A is a monoclonal antibody that appears to specifically recognize the AF 
molecule cloned from rat microglia; administration of TLD-1A8A in T-cell 
proliferation or mixed-leukocyte response assays increased T cells proliferation 
(Davidson and Hickey, 2004b).  
T-cell proliferation assays performed with rat serum containing AF showed that the 
antisecretory factor blocked the TLD-1A8A effect on T-cells, suggesting a role for AF 
in the regulation of T cell responses (Davidson and Hickey, 2004b). 
However, the effects on the immunological response observed in vitro did not clarify 
the nature of the interaction between AF and its antibody. Davidson and Hickey (2004b) 
hypothesized the existence of a receptor for AF on T cells surface which might be 
disrupt by the antibody, blocking the normal suppressing signal.  Alternatively, the 
binding of T cells membrane-associated AF to the antibody might activate the antigen 
presenting cells determining T cells proliferation (Davidson and Hickey, 2004b). 
Immunohistochemical analysis performed on rat tissue sections, treated with TLD-
1A8A, evidenced that in lymphoid organs such as spleen, thymus and lymph nodes, AF 
was highly expressed by macrophages and cells with dendritic morphology. In the gut, 
AF was expressed by scattered macrophages in the connective tissue of the villi and 
particularly in the Peyer’s patch, important in the immune surveillance of the intestinal 
tract. In the CNS, AF was found in blood vessels and perivascular cells, a bone marrow 
derived cell population important initiator and regulator of inflammatory reactions 
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 (Hickey, 2001; Davidson and Hickey, 2004a). Davidson and Hickey (2004b) observed 
that macrophages expressed AF even in absence of a direct immunological stimulus, 
even if the activation of T-cells induced an up-regulation of AF expression in 
macrophages.  
The immunological stimulus, due to experimentally induced autoimmune 
encephalomyelitis (EAE) in rats, modified the AF expression level and distribution in 
the inflamed nervous system, where the expression was enhanced in parenchymal 
microglia and infiltrating macrophages (Davidson and Hickey 2004b). In inflamed 
spinal cords, the mRNA expression showed a particular kinetics, with a drop at the 
onset of the clinical symptoms, a peak in coincidence with the highest disease severity 
and a decrease at baseline levels in correspondence with the complete recovery of the 
rats (Davidson and Hickey 2004b). Despite the accumulation of AF-positive leukocytes 
in the CNS during the course of the disease, no overt changes were apparent in either 
expression levels or distribution of AF in peripheral organs, such as spleen and lymph 
nodes. Since AF levels are at almost undetectable levels on circulating monocytes, 
Davidson and Hickey (2004b) suggested a mechanism whereby AF is upregulated on 
these cells at the area of inflammation upon macrophage activation and/or as a result of 
interaction with activated T lymphocytes. 
Pro-inflammatory factors such as LPS, IFN-γ up-regulated AF expression in rat alveolar 
macrophages only 72-96h after the treatment. The delayed kinetics was attributed by the 
Authors to the anti-inflammatory effect of AF, the AF up-regulation was associated 
with a redistribution of the protein within the cell, mainly in the cytoplasm and in the 
cell surface.  
Administration of the anti-AF antibody TLD-1A8A to rats with induced EAE increased 
the severity of clinical symptoms and the duration of the disease, with up-regulation of 
pro-inflammatory cytokines expression as IL-18 and IL-6 and decreased anti-
inflammatory IL-10 level. 
Davidson and Hickey (2004a, 2004b) hypothesized that the increased AF expression 
during the course of EAE could be a means of counteracting the pro-inflammatory 
environment and limiting the tissue damage. 
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The effects of AF on the nervous system 
 
The amino acids γ-aminobutyric acid (GABA) and glutamate are, respectively, the most 
common inhibitory and excitatory neurotransmitters in the CNS (Galofrè et al., 2009). 
Once in the synapse, they act on ionotropic receptors of GABA (GABAA) and 
glutamate (Galofrè et al., 2009). In mammals, overstimulation of GABAA activity 
results in central depression, whereas inhibition of GABAA receptor activity leads to 
general excitatory symptoms and convulsions (Madsen et al., 2008; Medina and 
Chudotvorova, 2006). Excitotoxicity occurs when ionotropic glutamate receptors are 
excessively activated and it is characterized by excitatory symptoms and degeneration 
of neurons (Leist and Nicotera, 1998; Onley, 2002). 
GABA exerts its effect on both CNS and enteric nervous system by increasing the Cl- 
conductance of the cell membrane.  
AF is expressed in the CNS and repeated challenges of rat intestine with cholera toxin 
increased the AF expression (Lange et al., 1985). 
In vitro studies, with isolated Deiters’cell membrane from rabbit’s glia, advanced the 
knowledge about the effects of AF and its mechanism of action on the nervous system. 
AF, purified from pig pituitary gland and its peptides, were shown to be potent blockers 
of Cl- and GABA permeation across isolated rabbit Deiters’cell membrane in a dose-
dependent fashion (Lange et al., 1985 and 1987; Rapallino et al., 2003). The AF 
concentration causing the half maximal inhibition was found to be 3·10-10 M, more than 
a thousand time lower than the met-5enkephalin, an opioid messenger considered one of 
the most potent inhibitor of GABA membrane permeation in vitro (Lange and Lönnroth, 
2001). 
AF might exerts its effect on the post synaptic stage since in vitro studies evidenced that 
AF binding to the Deiters cell membrane is reversible while AF had no effect on 3H-
GABA transport in integral cells (Lange et al., 1985). 
Nipecotic acid and bicuculline, respectively blocker of carrier mediated transport of 
GABA and selective blocker of GABAA receptor, abolished the AF effects on the 
neuronal membrane, while picrotoxin improved the AF inhibitory effect on Cl- 
permeation (Lange et al., 1987).  
Kim et al. (2005) suggested that AF acts as a regulator of the chloride homeostasis, thus 
possibly counteracting an excessive secretion of fluids in the intestinal lumen. 
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 AF protein is expressed in rat hippocampus and can pass the blood-brain barrier (Kim et 
al. 2005). Extra-cellular application of exogenous AF peptide to hippocampal slices 
resulted in a 40% reduction of GABAergic transmission while glutamatergic one was 
not affected (Kim et al., 2005). The same effect was also observed in hippocampal 
slices from rats immunized with cholera toxin administration or fed a diet containing 
hydrothermally processed cereals. To explain the AF mediated effect on GABA 
transmission, Kim at al. (2005) hypothesized that AF might decrease the postsynaptic 
response by an internalization of GABAA receptors and subsequent degradation in the 
proteasome.  
The enteric nervous system, enclosed in the wall of the gastrointestinal tract, regulates 
the motility and fluid transport, mainly without conscious control (Gwynne and 
Bornstein, 2007). Intestinal secretion is controlled by local reflexes which likely involve 
GABAergic neurons. When binds to GABAA receptors, GABA has a depolarizing and 
exciting effects on the enteric nervous system (Krantis, 2000). In vitro studies 
evidenced an inhibitory effect of GABA on motor activity of the guinea pig distal colon, 
inducing a relaxation in smooth muscle cells (Minocha and Galligan, 1993; Bayer et al., 
2002). Two AF peptides, differing in lengths and molecular weight and containing the 
same antisecretory domain, were tested to investigate the role of AF on colon 
contractions in guinea pig. Both peptides increased the contractions frequency, though 
at different levels, likely due to conformational differences that might have influenced 
the interaction with GABAA receptors (Harrison et al., 2004). The Authors suggested 
that the positive effect of AF on the colon contraction frequencies during pathological 
conditions could be a way to protect the mucosa from noxious agents (Harrison et al., 
2004). 
If the antisecretory factor acts as a negative modulator of GABAergic transmission also 
in the gut, it may counteract hypersecretion by decreasing the activity in secretory 
reflexes (Kim at al., 2005).  
 
 
AF-inducing Feed in Animal Nutrition 
 
Intestinal fluid accumulation can be caused not only by bacterial enterotoxins or 
neurohormones but even by hyperosmotic solutions. Intestinal secretion induced by the 
intake of solutions enriched with particular sugars, such as mannose and sorbitol, and 
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 amino acids as glycine and alanine, triggered AF production in rat and pig pituitary 
glands (Lönnroth and Lange, 1987). The concentration of monosaccharides and amino 
acids used were low, not able to induce clinical and subclinical diarrhoea. 
Cereals such as wheat, barley, rye, oats, rice, corn, millet, durra and sorghum, subjected 
to a patented hydrothermal process, similar to malting, achieve a determined content of 
sugars and amino acids that, once fed to animals or humans, triggers AF endogenous 
secretion. According to the patent (IPC8 Class: AA61K4700FI; USPC Class: 424439) 
the hydrothermally processed cereals can be defined as healthy and fresh kernels that 
has been subjected to malting. The hydrothermal process means that the grain kernels 
are steeped and thereafter are allowed to germinate at a carefully controlled water 
content and temperature until its sprout germs have developed. The germinated kernels 
are dried and desprouted. The drying can be driven so that the enzyme activity is 
changed to a more or less extent. The product then obtained is malt. The nutritive 
substances of the kernel have then, to a restricted extent, been hydrolysed and the 
enzymes of the sprout have been activated. This partial hydrolysis also facilitates the 
attack of the endogenous enzymes of the digestive system on the nutritive substances. It 
is obvious that a certain precooking or heat treatment also can increase the hydrolysis 
rate.  
As shown in Table 1, the hydrothermal process increases the glucose level from 0.3 
mg/g to up to 5.3 mg/g while for fructose, sucrose and maltose the concentration values 
are respectively raised up from 0.3, 8.4 and 0 to 3.1, 65.7 and 9.0 mg/g. The 
concentration of specific amino acids such as lysine, histidine, glutamic acid, 
tryptophan and isoleucine were also increased by the hydrothermal process (Bjorck et 
al., 2000). Since the European ban of in-feed antimicrobials the reduction of post-
weaning diarrhoea (PWD) incidence is a major goal for the pig industry (Castillo et al., 
2008).  
The Swedish government ban of AGP in 1986 prompted the research for the 
development of postweaning feeds antibiotics-free for piglet nutrition, that were 
economically and ecologically competitive (Lange and Lönnroth, 2001). According to 
Göransson et al. (1993, 1997), AF-inducing diets could be an important alternative to 
AGP and a useful tool to improve livestock efficiency and animal health and welfare. 
AF is present in sows colostrum and milk and there is a correlation between AF content 
in milk, its level in piglet’s blood and the incidence of diarrhoea in the litter (Lange et 
al., 1988). AF is transferred from the sow to the foetus across the placenta (Sigfridsson 
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 et al. 1995). In piglets AF activity in plasma has a cyclic variation, it declines at 
weaning, reaching the lowest level the third day post weaning (Lange et al., 1993). The 
onset of diarrheal disease is significantly correlated to the low plasma AF activity 
(Lange and Lönnroth, 2001). 
 
Table 1. Content of sugars and aminoacids in cereals before and after the hydrothermal 
process. From Björck et al. 2000). 
 
Content Before process 
 (mg/g DM) 
After process 
 (mg/g DM) 
Glucose 0.3-0.4 0.6-5.3 
Fructose 0.3-0.4 0.6-3.1 
Sucrose 8.4-14.4 36.8-65.7 
Maltose 0.0 4.0-9.0 
Histidine 0.0 0.06-0.25 
Glutamic Acid 0.12-0.20 0.42-0.44 
Lysine 0.03-0.06 0.15-0.29 
Tryptophan 0.09-0.22 0.28-0.45 
Isoleucine 0.0 0.05-0.30 
 
Lönnroth and Lange (1988) found that the AF production is stress sensitive. In rats, 
experimentally induced stress or injection of ACTH caused a rapid decrease of AF 
content in both plasma and pituitary gland. The physiological drop of AF activity at the 
weaning can be inhibited if piglets are fed an AF inducing diet (Lange and Lönnroth, 
2001). As shown in Table 1, piglets fed a diet with optimised sugars and amino acids 
content had increased AF activity in plasma, reduced diarrhoea incidence and improved 
growth performance: daily weight gain increased from 11.3 to 33.8%, meanwhile post-
weaning diarrhoea incidence decrease of 59.09% at least (Göransson et al., 1993).  
 
Table 2. Effects of AF-inducing diet on piglets growth performance, plasma AF content 
and post-weaning diarrhoea (PWD) incidence. Farm 1-5 from Göransson et al., 1993; 
farm 6 from Ulgheri et al., 2009. 
 
ADG, g    0-35d AF, units/ml plasma PWD, % 
  Farm      n° pigs 
C AF     C    AF      C    AF 
1 303   0.3 0.92 60 17 
2 169   0.31 0.91 66 27 
3 40 222 247 0.42 0.87 35 10 
4 54 266 325 0.79 1.05 15 4 
5 325 284 380 0.76 0.94 31 2 
6 144 351 378 - - - - 
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 An AF-inducing diet, made up with a milk substitute enriched with sugars and amino 
acids, was shown to be an effective growth promoter in calves, but only if reared in 
poor hygienic conditions (Lange and Lönnroth, 2001).  
Eggs are rich of AF, localized mainly in the yolk (Lange et al., 1994). According to 
Lange et al. (1994) the large amount of AF in the yolk could provide the chicken a kind 
of protection against gastrointestinal diseases until the animal capability to actively 
ecrete endogenous AF is restored, indeed the blood concentration of AF in chickens 
decreased from the hatching and start increasing at 21 days of age (Lange et al., 1994). 
As in pigs, the blood AF concentration in chicken is stress sensitive. The egg yolk 
powder from hens fed HPC is rich of the antisecretory factor protein that has proved in 
clinical studies to abolish diarrhoea in children affected by both acute and prolonged 
diarrhoea and to improve the symptoms in patients affected by irritable bowel diseases 
(Zaman et al., 2007; Eriksson et al., 2003a and 2003b).  
The exact mechanism of action of AF at the cellular level remains unclear. Laurenius et 
al. (2003) suggested that the hydrothermal processing of the cereals might causes an un-
masking of epitopes, which are not exposed in non-processed cereals and which are 
possible ligands for binding sites in the intestinal mucosa (Laurenius et al., 2003).   
 
 
AF and gut health 
 
In healthy small intestine villi absorb nutrients, while crypts secrete water and 
electrolytes. The main constituents of intestinal secretion are mucus, enzymes, water, 
Na+, Cl-, HCO3- and immunoglobulins A.  
Intestinal secretion is necessary to obtain a chyme with concentration of nutrients, water 
and electrolytes optimal for absorption processes and it also might have a function in 
the homeostatic mechanism as the control of fluid and acid/base balance in the body 
(Wapnir and Teichberg, 2002). In pathophysiological conditions intestinal secretion 
protects the mucosa by washing away and diluting the harmful substances (Lundgren, 
2002).  
During gastrointestinal diseases, regulatory mechanisms of secretion are altered and 
inflammation and diarrhoea, caused by either infectious or non infectious etiologies, are 
the result of changes in fluid and electrolytes transport in the small and/ or large 
intestine (Fordtran, 1967).  
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 Enteric pathogens that cause the most severe diarrhoea diseases are rotavirus, Vibrio 
cholera, Shigella spp, Salmonella spp, and enterotoxigenic Escherichia Coli (Petri et al. 
2008). The intestinal hypersecretion caused by V. cholera toxin and E. coli labile toxin 
(LT) has been deeply studied in experimental animals. Cholera toxin (CT) induced 
diarrhoea has been considered a prototype of enterotoxin-caused diarrhoea, because it 
does not cause histological changes in the intestine despite substantial rates of net fluid 
secretion (Field et al., 1972).  Both CT and LT are heterohexameric molecules which 
consist of a single A-subunit and five identical B-subunits (Fan et al., 2004). Despite 
their similarities, CT and LT induce secretion by different mechanisms at level of 
receptors and transductional pathways involved in the secretory response (Griffiths and 
Critchley, 1991; Mourad et al., 1995). 
Both cholera toxin and E. coli LT attach to GM1-ganglioside via the B-subunit and the 
binding itself triggers the toxin internalization. Inside the cell, A-subunit catalyses 
ADP-ribosylation of the Gs-subunit of adenylate cyclase, increasing mucosal cAMP 
level (Moss et al., 1981). CT and cAMP stimulate active Cl- secretion by activating or 
inserting Cl- channels into the apical membrane of the crypt cells and inhibit 
electroneutral NaCl absorption by decreasing the activity of Na+/H+ and Cl-/HCO3- 
exchange in villous cells, without interfering with the glucose stimulated Na absorption 
(Petri et al., 2008). Studies with fish TTX (tetrodotoxin) showed that CT interacts with 
the enteric nervous system, inducing the secretion of neurohormones as 5-
hydroxytryptamine (5-HT) and vasoactive intestinal peptide (VIP) (Cooke et al., 1994; 
Cassuto et al., 1981).  
LT is the major virulent factor of ETEC (Holmgren and Svennerholm, 1992); it was 
found that LT binds to several brush border galactoproteins only weakly recognized by 
CT, and was suggested that binding of LT to this additional receptors might have a role 
in the intestinal secretion pathophysiology (Mourad et al. 1995). Recent studies 
demonstrated that, beyond its ability to bind to different glycolipids on enterocytes 
surface, LT binds to lipopolysaccharides (LPS) on the surface of E.coli (Horstman and 
Kuehn, 2000). As a result of the LT-LPS surface interaction, more than 95% of secreted 
LT is found associated with E. coli outer membrane vesicles, rather than being secreted 
in a soluble form (Horstman and Kuehn, 2000). LT is able to mediate the internalization 
of intact outer membrane vesicles into host cells (Kuehn and Kesty, 2004). In addition, 
competitive binding assays and microscopy with fluorescently labeled ETEC vesicles 
revealed that GM1 and LPS binding sites are distinct since binding process can occur in 
 42
 the same time (Horstman and Kuehn, 2000). In cultured human intestinal cells, a third 
binding substrate for LT are the sugar residues of the receptor molecule of human blood 
group A antigen (Holmner et al., 2007). 
According to Mourad et al. (1995), LT induces secretion without involving 5-HT, 
whose receptors antagonist had no effect on LT-induced fluid and electrolyte secretion. 
Clostridium difficile Toxin A (CDA) has a marked pro-inflammatory effect on the 
intestinal mucosa causing fluid accumulation, inflammation and tissue damage. It binds 
to glycosphingolipids receptors and is internalized in the enterocytes (Lönnroth et al., 
2003). Inside the cell, toxin A exerts enzymatic activity, by catalysing glucosydation, 
triggering the secretion of multiple inflammatory mediators as substance P, histamine, 
nitrogen oxide and prostaglandin (Kelly et al., 1998). 
Rotavirus infection is one of the leading causes of infantile gastroenteritis. The virus 
infects the mature enterocytes that line the small intestine and, consequently, it impairs 
activities of intestinal disaccharides and Na+-solute symports coupled with water 
transport. Rotavirus’ protein NSP4 induces a calcium ion-dependent chloride secretion, 
disrupts SGLT1 transporter-mediated reabsorption of water, causes maldigestion of 
carbohydrates and likely activates the calcium ion-dependent secretory reflexes of the 
enteric nervous system. The malabsorption of nutrients in the intestine is associated 
with inhibited water reabsorption and can lead to diarrhoea and malnutrition (Lorrot and 
Vasseur, 2007).  
Shigellosis is one of the major causes of diarrhoea-related morbidity and mortality in 
developing countries, transmitted through contaminated food and water as well person 
to person contact  (Kotloff, 1999, Baldi et al., 2009). Effects of Shigella spp. infection 
are inflammation, mucosal ulceration and bleeding of the gastrointestinal tract (Baldi et 
al., 2009).  
 
AF and enteropathogenic bacteria 
The AF protein and its derivatives seem to be the most potent inhibitor of intestinal 
hypersecretion of various aetiologies. Indeed, less than a picomole of human 
recombinant AF (rAF) was shown to inhibit cholera toxin induced fluid secretion in a 
rat model (Johansson et al. 1997). Torres et al. (1991) suggested that AF is released as a 
response to the hypersecretion itself, rather than to the causative agents. Grøndal and 
colleagues (2002) tested different AF derived peptides on pig intestinal loops 
challenged with different secretagogues including CT, LT and 5-HT and found that AF 
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 inhibited intestinal fluid accumulation in the proximal small intestine of CT-treated 
loops while there was no effect in the distal part.  
In vivo experiments conducted with rats demonstrated that repeated exposition to CT 
causes a long-lasting over-expression of AF in the intestinal mucosa able to counteract 
the CDA-induced signal, thereby preventing intestinal inflammation and fluid secretion 
(Lönnroth et al., 2003). The CT-induced tolerance to CDA might be mediated by the 
enteric nervous system (Lönnroth et al., 2003). CDA causes the secretion of substance P 
that triggers the release of a wide range of chemical mediators by the mucosal 
enterocytes (Goyal et al., 1996). In the gut, AF is highly expressed in the submucosal T-
lymphocytes, suggesting a sort of immunological memory. The antisecretory activity of 
the AF protein and its derived peptides is usually estimated by in vivo assay based on 
graded inhibition of CT-induced secretion in intestinal loop model (Lange 1982; Lange 
and Lönnroth 2001). 
In toxin challenged experimental animals, the AF antisecretory effect differs with the 
type of toxin and AF administration route. Human rAF administrated to rat, via penis 
dorsal vein or directly into the lumen of intestinal loop, just before or one hour after the 
Cl. difficile Toxin A challenge, reduced mucosal damage and fluid accumulation by 60-
70% (Johansson et al., 1997). Intravenous injection of rAF counteracted the intestinal 
hypersecretion but not the intestinal epithelial damage caused by okadaic acid 
(Johansson et al., 1997). 
The in vivo assay used to evaluate the AF activity in plasma is based on graded 
inhibition of CT-induced hypersecretion in ligated loops of the rat small intestine 
(Lange, 1982). As observed by Johansson et al. (2009), this method is reliable and 
reproducible, it is labor intensive, technically difficult, and furthermore, it requires a 
large number of experimental animals.  
Polyclonal antibodies, raised against linear epitopes of AF proteins and its derived 
peptides, were used to investigate the possible changes in the protein structure 
responsible for its biological activities (Jennische et al., 2006). These antibodies were 
used to screen the presence of conformational variants of the antisecretory protein in the 
pig central nervous system, though they were not able to discriminate between active 
and inactive AF form, a great inconvenient since most of the AF present in plasma is in 
an antisecretory inactive state (Jennische et al., 2006).  
A first step in the development of an in vitro assay, able to detect the AF active forms, 
has recently been made with the realization of an ELISA test. This in vitro assay has 
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 been developed using monoclonal antibodies raised against human placenta AF 
(Johansson et al., 2009). The efficacy of the ELISA test, compared with in vivo assay 
(ligated rat intestinal loop), was assessed by analysing AF activity in plasma samples 
from volunteers which ate the hydrothermally processed cereals. The plasmatic-AF 
values obtained by ELISA determination well correlated with the AF-activity as 
measured by bioassay with the intestinal loops (r = 0.85) (Johansson et al., 2009). 
 
AF and Irritable Bowel Disease  
Inflammatory bowel disease (IBD) is a complex disorder, characterized by chronic 
inflammation of the gastrointestinal tract, abdominal pain or discomfort, associated with 
altered bowel habits (Ferguson et al., 2007). The two main types of IBD are ulcerative 
colitis (UC) and Crohn disease (CD). UC is characterized by chronic mucosal 
inflammation and epithelial dysfunction in the large intestine, which causes open sores, 
ulcers and bleeding. The main symptom of UC is frequent bloody diarrhoea (Eriksson et 
al., 2003a). UC causes inflammation and ulcers in the top layer lining of the large 
intestine while Crohn’s disease can affect all layers of the intestine. CD can affect any 
area of the gastrointestinal tract, from the mouth to the anus, but it most commonly 
affects the ileum. The swelling extends deep into the lining of the affected organ, 
causing pain and frequent bowel movement.  
IBD is currently considered as a bio-psychosocial disorder with disturbances of motor 
function, heighted gut sensitivity, and possibly central nervous system disturbances 
(Levy et al., 2006). There is a genetic component in the incidence of IBD, since 
approximately 20% of people with one form of IBD have a blood relative with IBD 
(Ferguson et al., 2007). Studies with twins showed that 36% of monozygotic twins 
share the disease, compared to only 4% of dizygotic twins (Jess et al., 2005). The 
highest incidence rates and prevalence of IBD have been reported from northern 
Europe, the UK, and North America, though the rates are beginning to stabilize. On the 
contrary, rates continue to rise in low-incidence areas such as southern Europe, Asia and 
in most developing countries (Loftus et al., 1998). Curative treatment for IBD has yet to 
be established, up until now therapeutic focus is on alleviating symptoms (Eriksson et 
al., 2003a).  
Bjorck et al. (2000) evaluated the effect of an increased endogenous AF secretion on the 
clinical outcome in patients suffering IBD. Patients with long lasting UC or CD 
received a diet containing either placebo cereals or HPC, without changing food habits 
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 and conventional medical treatment. The outcomes were evaluated by analysing 
objective and subjective data. Every patient kept a diary to daily record number of 
bowel movements and stools consistency, clinical improvement or clinical deterioration 
was plotted as percentages on a visual analogue scale (VAS score) and expressed as 
percentage of change. The study demonstrated that a diet supplemented with HPC was 
able to induce an increase of AF in plasma of patients suffering irritable bowel 
syndrome (IBS). Increased AF level in plasma was associated to an improvement of 
patient’s welfare, reduced frequency of bowel movement and solid stools. Rectal 
biopsies analysed by immunohystochemistry showed that HPC supplementation 
induced a larger number of AF positive cells compared to biopsies from the patients 
receiving the placebo cereals. However, a correlation was found between AF content in 
plasma and biopsies cells staining. No effects were observed on C reactive protein in 
plasma. The AF values in plasma declined slowly after the end of the experiment. 
The influence of orally administrated AF, provided by egg yolk with a high AF content, 
was evaluated in a randomized double blind study which involved 20 patients suffering 
from acute onset of UC (Eriksson et al., 2003). The study concluded that AF, used as a 
supplement to conventional pharmacological and nutrition therapies, can help to 
alleviate inflammation as shown by rectal biopsies. Passive administration of AF by the 
means of AF-rich egg yolk powder, followed by active induction through a diet 
supplemented with HPC, induced the regression of Crohn disease in a patient with long 
standing disease. The patient had a resected colon and was not responsive to 
conventional pharmacological treatment (Eriksson et al. 2003b). Another study by 
Eriksson et al. (2003a) was conducted on patients with acute attack of ulcerative colitis 
receiving AF or placebo treatment as a supplement to the conventional pharmacological 
and nutritional therapy usually performed. The AF therapy showed to have a positive 
effect on the inflammatory reaction of colon mucosa. Rectal biopsy analysis evidenced 
a reduction in the relative number of neutrophils and eosinophils granulocytes in the AF 
group but no effect on the intestinal secretion was observed.  
However, Ekesbo et al. (2008) reported no additional beneficial effects of HPC diet 
supplementation in a placebo-controlled diet study with irritable bowel syndrome (IBS) 
patients that received placebo-cereals or active AF inducing cereals. It was noted that 
both groups’ general conditions, measured by a VAS score, improved regardless of 
which diet was consumed, likely due to a good fibre amount of the diets, that may have 
had a bulking effect and reduce diarrhoea. 
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AF and short bowel syndrome disease 
Short bowel syndrome (SBS) can appear after intestinal surgery, radiation injury or 
from loss of function due to vascular insufficiency. It can result in malnutrition and 
dehydration due to malabsorption of fluid, electrolytes, minerals and nutrients (Tilg, 
2008). It is often associated with intestinal failure requiring parenteral nutrition, 
impairment of health related quality of life (HRQoL) and morbidity (Messing et al., 
1999; Nightingale, 2001).  
Lange et al. (2003) performed a study on patients with resected intestine and found that 
the extent of AF activity and the ability to maintain a high level of plasmatic AF after 
HPC treatment is significantly correlated to the length of the remaining small intestine. 
The study found that a length of at least 100 cm of small intestine is required to induce 
an improvement of AF-activity by dietary means and the presence or absence of the 
large intestine did not appear to affect AF activity.  
Pagoldh and colleagues (2008) conducted a double blind trial to investigate the effects 
of diet supplemented with HPC or with non processed cereals (NPC) on HRQoL in a 
heterogeneous group of patients affected by SBS of various etiologies, with different 
short bowel length ( which had been subjected to different intestinal surgical 
techniques). NPC were more effective in reducing the daily faecal volume, especially in 
patients with ulcerative colitis, probably because of the high content in gel forming 
dietary fibre that improved the fluid absorption. The surgical techniques seemed to 
influence the clinical effects of the cereals supplementation (Pagoldh at al., 2008). 
Moreover, the effects of the diet supplementation were more evident in the last part of 
the trial, likely due to sensitization processes of the mucosa, which was independent 
from the type of cereals used in the first part of the trial. 
According to the authors, an interesting approach to SBS would be a supplementary diet 
targeting increased viscosity of the intestinal content that could prolong the transit time 
and, as a consequence, improve the nutrient uptake (Pagoldh at al., 2008).  
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 AF and endocrine diarrhoea 
Endocrine diarrhoea is caused by an imbalance of specific hormones which inhibit 
water and electrolyte absorption and/or increase fluid secretion or stimulate motility. 
The most important hormones involved in the regulation of intestinal secretion are VIP, 
serotonin, substance P, prostaglandin E2, calcitonin, thyroxin, pancreatic polypeptide 
hormone (Dodi et al., 1996). 
Carcinoid syndrome and medullary thyroid carcinoma (MTC) can lead to an alteration 
of the hormones balance. Carcinoid syndrome refers to a range of symptoms that occur 
as a result of carcinoid tumours. Carcinoid tumours originate in the cells of the 
neuroendocrine system, could occur anywhere along the gastrointestinal tract and in the 
lungs and are characterized by production of serotonin (5-HT) (O’Toole et al., 1999). 
The syndrome is characterized by endocrine induced diarrhoea with flushing and 
bronchospasm, caused by the tumours ability to secrete vasoactive peptides (Dodi et al., 
1996). MTC is a neuroendocrine tumor that develops in the thyroid C cells and occurs 
either as an erratic event or secondary to a germline mutation with an autosomal 
dominant pattern of inheritance (Kaltsas et al., 2004). Thyroid C cells are responsible 
for production of both calcitonin and carcinoembryonic antigen (CEA) (Flemming et 
al,. 1999). Neuroendocrine tumours may induce severe persistent diarrhoea, sometimes 
therapy-resistant (Waangberg et al., 1996). Laurenius et al. (2003) investigated the 
effects the AF therapy, AF-rich egg yolk powder or HPC, on patients suffering from 
endocrine diarrhoea due to midgut carcinoid syndrome or metastasizing MTC. This 
study showed that even though the severely ill patients were optimally medicated, 
several of them responded positively to the AF-therapy. Passive intake of AF had 
positive effects on the frequency of bowel movements, indicating that AF was still 
active after passing the upper gastro-intestinal tract. Compared to the passive AF-
therapy, the HPC therapy required a larger intake volume, which was difficult to reach 
in severely ill patients (Laurenius et al., 2003). Thus AF-rich egg yolk powder could be 
the best option for patients who are not able to ingest large amounts of food.  
 
 
AF therapy: a tool to prevent child diarrhoea in developing countries? 
 
As previously stated, diarrhoea remains a problem amongst children especially in 
developing countries, in some cases even life threatening. Severe malnutrition and 
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 infections are the main cause of the children’s premature and avertable deaths (Brown, 
1990). Diarrhoea can be prevented by improving the hygienic conditions, through 
vaccination and encouraging mothers to breastfeed their infant (Mihrshahi et al., 2008). 
Breast milk is easily digestible and contains antibodies that can protect the infant from 
bacterial and viral infections. Furthermore, it aids the development of the child’s 
immune system. According to Ziyane (1999), exclusively breastfed infants under two 
months are 25 times less likely to die of diarrhoea related illness than non-breastfed 
infants. However, in many diarrhoea cases, breastfeeding alone does not suffice 
(Saleemi et al., 2004).  
In a study conducted in Pakistan on children suffering from acute and prolonged 
diarrhoea episodes, was found that when given B 221, a medical food based on AF-rich 
egg yolk powder, the incidence of diarrhoea subsided (Zaman et al., 2007). The study, 
which lasted 3 days, involved 240 children from 6 to 24 months; every 5 hours they 
were randomly given 2 g of B 221 or placebo (regular egg yolk powder), dissolved in 
rehydratation solution. In children suffering from acute diarrhoea (less than 7 days of 
diarrhoea illness), the AF administration improved frequency and consistency of the 
stools, the clinical outcome after 3 days was positive for 83% of the children fed B 221, 
while the response to placebo was positive in only 54% of children. In children with 
prolonged diarrhoea, B 221 treatment resulted in a 91% successful clinical outcome, 
compared to the placebo group which only had a 63% success rate.  
As evidenced by Zaman et al. (2007), it was of note that the medical food containing 
AF counteracted diarrhoea of different etiologies, since it was unlikely that the children 
involved in the study were infected by the same agent. Dosing and mode of 
administration of B 221 are still yet to be understood, but according to authors, higher 
dosage might be useful in the management of acute diarrhoea in children, specially in 
developing countries, avoiding the appearance of prolonged diarrhoea, with its 
threatening consequences. 
Svensson et al. (2004) found that the AF can be induced in maternal milk by 
hydrothermally processed cereals intake. Furthermore, the AF-inducing diet prevented 
the mastitis, a painful infection and inflammation of the breast tissue, likely due to the 
anti-inflammatory properties of the antisecretory factor. Thus, HPC intake in lactating 
women might achieve the double goal to prevent mastitis in the mothers and diarrhoea 
in children. 
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 AF therapy in Ménière’s Disease 
 
An increase in AF blood plasma has been found to reduce symptoms in patients 
suffering from Ménière’s disease, a disturbance of the inner ear that can affect hearing 
and balance, characterized by episodes of vertigo, tinnitus and progressive hearing loss 
(Hanner et al., 2004). It was first hypothesized that endolymphatic hydrops cause 
dilation of the cochlear duct affecting the endolymph drainage process. Recent findings 
suggest that impaired production or resorption of endolymph and/or transport across 
membranes, appear to be major factors in the pathophysiology of Ménière’s disease 
(Hanner et al., 2004, 2009). Dysfunctions of many structures of the inner ear and of the 
sympathetic nervous system are likely to be involved in creating the symptoms of this 
disease (Hanner et al., 2004, 2009).  
Experimental evidence about the role of the antisecretory factor as a regulator of fluid 
transport across the mucosal membranes and its anti-inflammatory properties, induced 
Hanner and colleagues (2004) to perform a pilot study on patients suffering Ménière’s 
disease, in order to investigate the effect of increased AF plasma concentration on the 
frequency and extent of vertigo, which are the main symptoms of this disease. The 
study required that the patients received 1g/kg bw/day of HPC, divided into two to three 
dosages over 2-4 weeks. Patients were instructed to keep a diary in regards to their 
subjective symptoms, including frequency, duration of vertigo, fluctuations of hearing. 
Although the study was performed on a  small number of patients (24), the results were  
interesting since in about 50% of patients the attacks of rotatory vertigo diminished or 
completely disappeared, with reduced final AAO-HNS functional level scale (America 
Academy of Otolaryngology-Head Neck Surgery, 1995; range 1 to 6) (Hanner et al., 
2004). Even if there was a positive correlation between plasma AF activity after the 
treatment and the reduction of vertigo (r=0.65, P< 0.001), the response to the diet was 
individual and not related to the severity of the symptoms (Hanner et al., 2004). The 
findings of the study confirmed that AF-inducing diet could be useful in some 
Ménière’s disease patients and also reinforced authors’ idea that AF could be involved 
in the inner ear homeostasis. Following the success of the pilot study, Hanner et al. 
(2009), performed a double-blind study on a larger number of patients (n=51) for a 
longer period of time (3 months). Patients were randomly assigned to two groups: a 
control which received placebo cereals and the HPC group. In the HPC group, 14 of the 
27 patients experienced a decrease in the symptoms, while in the control group only two 
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 participants reported decreased vertigo severity (Hanner et al., 2009). Once the double 
blind arm of study was concluded, the participants of the control group were offered the 
option to receive the active cereal treatment for further three months: 22 patients 
accepted, of these 17 had alleviated symptoms. According to Hanner et al. (2009), the 
results from the open arm of the study might have been influenced by the expectations 
of the patients. In both trials the feeding treatment had no effects on clinical 
otoneurological status of patients, assessed before and after the treatment by pure tone 
average and speech audiometry tests. Therefore, the HPC treatment exerted its effect 
only on the vertigo component of the disease. A clear explanation of the mechanism of 
action of AF remains unknown, however many experiments and clinical studies indicate 
that AF can normalize water and ion transport. It has been shown that AF interacts with 
the lipid raft protein flotillin-1, and they are both expressed in the inner ear of the rat 
(Hanner et al., 2004), as well as the human cochlea and endolymphatic saccus 
(Jennische et al., 2003). Hanner et al. (2009) suggested that the interaction between AF 
and flotillin-1 might cause a down-regulation or a re-organization of aquaporin 
channels, thus regulating the homeostasis of endolymph. 
 
 
New insight on AF properties 
 
Brain edema, haemorrhage, obstruction or derangement of the blood-brain barrier, can 
lead to increased intracranial pressure (ICP) that can damage brain function resulting in 
inflammation, with possible persistent neurological and psychiatric malfunctions (Vink 
et al., 2003; Hoane et al., 2006; Säljö et al., 2009a and b). The extent of brain damage is 
related to the severity and length of ICP increase (Jennische et al., 2008).  
In human, blast related brain injuries are known to cause brain edema, vasospasm and 
intracranial haemorrhage (Armonda et al., 2006). The current therapeutic options 
applied in counteracting elevated ICP are not indicated at pressure levels lower than 
25mm Hg. However, less is known about the medium and long term effects of levels of 
ICP lower than the treatment threshold on physical, psychological function of patients 
(Jantzen, 2007). The effects of exposure to low and mild blast levels on brain injury is 
increasing of interest due to the involvement of large numbers of troops in the Afghani 
war, where soldiers are often subjected to traumatic brain injury without damage to the 
head (Säljö et al., 2009). It was recently reported that in a rat model low blast 
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 overpressure in a shock tube (10-30-60 kPa) impaired cognitive functions, assessed by 
the Morris Water Maze, and caused an elevated intracranial pressure in a dose 
dependent manner (Säljö et al., 2009a). The same experiment was repeated with rats fed 
or not a diet supplemented with 20% of hydrothermally processed barley (Säljö et al., 
2009b). The study showed that the inclusion of hydrothermally processed barley in the 
rats diet prevented the impairment of cognitive function and drastically reduced the ICP 
elevation. The peak of intracranial pressure was reached 10 hours after rats exposure to 
both 30 and 60 kPa, though in rats exposed to 60 kPa there was a first smaller peak after 
10 minutes. At 10 hours from the overpressure exposure, the mean ICP in rats of the 
control group subjected to 30kPa and 60 kPa raised respectively of 90 and 145%, while 
in rats fed hydrothermally processed barley the ICP increased of 60 and 50%, 
respectively. The feed treatments had no effect on the initial peak, recorded after 10 
minutes from the exposure at 60 kPa. Säljö et al. (299b) suggested that the diet 
supplementation with hydrothermally processed barley reduced brain edema but the 
mechanisms behind this protective effect remain unknown. 
In a rat experimental model of herpes simplex encephalitis, induced by type 1 virus 
(HSV-1), AF-16 peptide was used to suppress the raised ICP (Jennische et al., 2008). 
The intranasal instillation of AF-16 peptide granted a complete rescue of rats receiving 
25μg twice daily from the forth day after infection. Prevention of neurological 
malfunctions, usually associated with encephalitis, was found to be dose dependent. In 
rats receiving 1μg of AF-16 twice daily, starting immediately after the infection, there 
was a moderate mortality, while in animals of the untreated group the mortality was 
about 90% (Jennische et al., 2008). The AF-16 peptide reduced the ICP increase and 
fluctuations, and also abolished the pressure peaks in treated rats. Jennische et al. 
(2008) suggested that the AF-16 mediated suppression of increased intracranial pressure 
in infected rats to non-injurious level is might be the cause of abrogated neurological 
malfunctions. 
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 Table 3. A summary of the clinical outcomes obtained with the “AF-therapy”. 
 
Study Study Population Treatments Results 
 Diarrhoea of different etiology 
Laurenius 
A et al. 
2003 
Patients affected by midgut 
carcinoid syndrome or 
metasizing medullary 
thyroid carcinoma (MTC) 
 
Participants (n): 8 
1st  period: AF-rich egg yolk 
for four weeks 
2nd period: Double-blind 
crossover period with HPC 
and control cereals (CC) for 
six weeks 
 
1st period: 7 patients 
experienced  about 25% 
decrease in number of bowel 
movements 
2nd period: patients 
experienced increase solidity 
of stools. 
Zaman S et 
al. 2007 
Children 6-24 months of 
age affected  by acute 
diarrhoea and prolonged 
diarrhoea  
Each patient was randomly 
given 2 g of either regular egg 
yolk or AF containing egg 
yolk (B221) every 5 hrs for 3 
days along with an oral 
rehydration salt solution. 
Administration of B 221 
improved health in both 
groups but no statistical 
significance was found, most 
likely due to short 
experimental period.   
IBD-IBS 
Erikkson A 
et al. 2003 
Patients suffering from 
acute ulcerative colitis 
 
Participants (n): 20 
 2g of AF-rich egg yolk drinks 
4x daily for 14 days or 
placebo treatment in addiction 
to the standard 
pharmacological therapy 
Results were not statistically 
different 
Finkel Y et 
al. 2004 
Patient 1 (P1): 16 y old 
male prolonged tiredness, 
anemia, abdominal pain; 
 
Patient 2 (P2): 16 y old 
male diagnosed a left sided 
ulcerative colitis 
 
54 g/d of HPC for a 2 week 
period in addition to medical 
treatment  
P1 experienced an increase in 
hemoglobin, decrease of 
intestinal permeability and 
improvement of clinical 
symptoms 
 
P2 had a decrease in loose 
stools and improvement of 
general well being 
Erikkson A 
et al. 2003 
1 patient suffering from 
Crohn’s Disease 
 
As supplement to the 
conventional medical therapy: 
AF-rich egg yolk powder 4x/d 
for 14 days. In addition on 
day 4 of treatment finely 
ground HPC administered 
(0.5g/kg bw/d) by day 10 
ungrounded HPC given to 
patient (1g/kg bw/d) 
Approximately 80% decrease 
of average daily stools 
Ekesbo R 
et al. 2006 
Patients affected by IBS 
 
Participants (n): 62 
100 g of HPC or placebo 
cereal a day 
Overall improvement in 
symptoms irrespective of diet 
Short Bowel Syndrome 
Pagoldh M 
et al. 2008 
Short Bowel Syndrome 
patients 
 
Participants (n): 26 
Randomized double-blind, 
cross-over multicentre 
prospective study. Patients 
received HPC or placebo 
cereals then treatment was 
switched between group  
Faecal volume significantly 
decreased after regular cereal 
treatment  
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 Aim of the thesis 
 
Nowadays nutrition is considered a possible tool to improve health and wellness in both 
human and animals. Foods like grains, tomatoes, milk, are gaining interest for the health 
promoting activity of their components such as β-glucans, lignans, lycopene or 
conjugated linoleic acid.  
In pig intensive farming, stressful events related to premature weaning, have a negative 
impact on animals health and welfare. Indeed early weaning exposes the piglets to 
nutritional, social and environmental stresses when piglets immune and gastrointestinal 
systems are not fully developed (Partanen and Mroz, 1999).  
For a long time, the employ of in-feed antimicrobials has been strategic in animal 
nutrition by reducing the detrimental effects of premature weaning on piglets health and 
growth performance. 
Consumer and political opinions, and a scientific concern that resistance selected in 
animals might be transmitted to humans to the detriment of their health led to a 
complete ban of in-feed antimicrobials in 2006.  
Several nutritional approaches and alternative substances have been proposed but, so 
far, none of these showed to be as effective as antibiotics on growth promotion and 
disease prevention (Lallès et al., 2007, 2009). Among the alternatives so far proposed, 
the immuno-modulating substances are gaining interest, since the correct development 
of both innate and acquired immune system of the piglets is strategic in determining the 
outcomes of a large exposure to antigens and weaning-associated stress (Gallois et al., 
2009).  
The antisecretory factor is present in sows’ milk and colostrum, a protective effect of 
milk AF on offspring gastrointestinal disease has been hypothesized (Lange and 
Lönnroth, 2001). In vitro and clinical studies evidenced the AF (potent) capability to 
counteract intestinal fluid imbalance of various aetiologies, meanwhile recent reports 
focused on its immunomodulatory and anti-inflammatory properties.  
AF-inducing diets, such as the hydrothermally processed cereals, appear to be possible 
candidates as replacers of antibiotic growth promoters. 
However, the mechanism of action behind its biological activity has not yet been 
clarified and, so far, few data are available on pig field trials. Furthermore, compared to 
its use in human nutrition, the proper level of diet supplementation has not been 
defined. 
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 A first goal of this thesis has been to summarize the information about the antisecretory 
factor protein and its derivates, evidencing the potential beneficial effects of AF-
inducing diets on both human and animal health and welfare. 
The main aim of this work has been to verify the efficacy of HPC diet supplementation 
as alternative to AGP in weaned piglets and evaluate the anti-secretory and anti-
inflammatory activities of AF-16 peptide in in vitro models.  
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 Effect of hydrothermally processed cereals (HPC) on 
the performance of weaned piglets. 
 
 
Abstract 
Antisecretory factor (AF) is an endogenous protein that has shown to be a potent 
inhibitor of intestinal fluid secretion and inflammation. AF content in sows’ milk is 
important for protection against neonatal diarrhoea in suckling piglets. Feeding specific 
hydrothermally processed cereals (HPC) has proven to increase the plasma level of AF 
and to be helpful in counteracting diarrhoea in domestic animals. The aim of the study 
was to investigate the effects of an AF-inducing diet on piglets growth performance and 
intestinal mucosa.  
144 weaned piglets with a body weight (BW) of 6.35 ± 0.52 kg were randomized for 
sex and weight and allotted to 3 groups fed ad libitum: C) control diet; T1) control diet 
with 3% supplemental HPC; T2) control diet with 6% supplemental HPC. On day 0, 14, 
and 42, animals were weighted, feed consumption and feed:gain ratio (FCR) were 
determined. Blood samples were collected (n=6 animals per treatment group) to 
determine the effect of HPC on the intestinal enterocytes. None of the piglet showed 
diarrhoea during the study.  
Piglets fed the diet supplemented with 6% of HPC had higher (P<0.05) final BW 
compared to piglets fed the control diet. ADG was higher for the piglets fed the diet 
supplemented with 6% HPC 14 days after weaning (P<0.05) and during the whole 
experimental period (P<0.05). During the second growing phase (14-42 d) animals fed 
6% HPC grew more than piglets receiving 3% HPC supplemented diet Piglets fed T2 
had a lower FCR (P= 0.05) than piglets fed C. No differences were detected on feed 
intake and blood parameters. Plasma levels of I-FABP, a parameter of the intestinal 
health status, were low for all animals and did not significantly differ between treatment 
groups. In vitro digestion assays evidenced a relevant simple sugars content and higher 
rate of starch hydrolysation in the HPC diets compared to control diet. The difference in 
growth performance observed between groups might be related to a balanced supply of 
energy-yielding nutrients and amino acids in the diets. The findings of this experiment 
support the use of HPC as a natural alternative to AGP. 
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 Partial results from this work have been presented as a poster at XI Symposium on 
Digestive Physiology of Pigs, Spain 20th – 22nd May 2009. Accepted for publication on 
Livestock Science. 
 
 
Introduction 
 
The reduction of post-weaning diarrhoea is one of the main challenges for the pig 
industry after the ban on antibiotic growth promoters (AGP) in the EU (Castillo et al., 
2008).   
Antisecretory factor (AF) is an endogenous protein that has shown to be a potent 
inhibitor of intestinal fluid secretion and inflammation and thereby counteracting 
dehydration induced by enterotoxins associated with post-weaning diarrhoea.  
AF is transferred from the sow to the foetus across the placenta and is present in 
colostrum and milk. According to Lange et al. (1988) there is a correlation between AF 
content in milk, its level in piglet’s blood and the incidence of diarrhoea in the litter 
(Lange et al., 1988). In piglets, the AF activity in plasma has a cyclic variation and at 
the weaning it declines, reaching the lowest level the third day of weaning (Lange et al., 
1993). Lönnroth and Lange (1988) found that the AF production is sensitive to stress. 
According to Lange and Lönnroth (2001), the onset of diarrhoeal disease is significantly 
correlated with the low plasma AF activity and the physiological drop AF activity at the 
weaning moment can be inhibited, provided that the piglets eat an AF inducing diet. 
Swedish researchers optimized a hydrothermal process, similar to malting, that modifies 
the availability of sugars and amino acids of cereals, able to stimulate AF endogenous 
secretion.  
AF content in sows’ milk could be a protection factor against diarrhoea in suckling 
piglets (Lönnroth et al., 1988). Several clinical studies on humans and pigs have shown 
that the hydrothermally processed cereals improved the intestinal fluid balance and 
general health status (Lange and Lönnroth, 2001). In animal husbandry AF-inducing 
diets, owing to their antisecretory activity and anti-inflammatory action on intestinal 
mucosa, could be a valid alternative to antibiotic growth promoters, especially in swine 
production, to counteract post-weaning diarrhoea. Furthermore the higher availability of 
highly digestible starch is an important energy source for the animals, in a critical 
period characterized by low voluntary feed ingestion. 
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 The aim of the study was to investigate the effect of an AF-inducing diet on piglets 
growth performance and intestinal mucosa. 
 
 
Materials and Methods 
 
 
Animals and diets 
The trial was carried out at the Cerzoo experimental farm. 144 weaned piglets (Large 
White) were selected in a commercial herd. The animals were weaned at 4 weeks of age 
with an average initial BW of 6.35 ± 0.52 kg. All piglets were healthy at the beginning 
of the study. The piglets were randomized for sex and body weight and housed in 36 
pens (4 pigs/pen). The hydrothermally processed wheat (HPC) was provided by Viking 
Malt (Lantmännen, Sweden), while wheat (W) was acquired from the market.  
The feeding treatments were: C) control diet (Luigi Ferrari Mangimi, Sarmato, Italy); 
T1) control diet plus 3% HPC (Varian System Plus I, Lantmännen, SW); T2) control 
diet plus 6% HPC.  
The basal diets for the first and second growing periods were prepared by single mixing 
in Luigi Ferrari feed mill (Sarmato, Italy). The complete diets of the first and second 
growing periods with the inclusion of the hydrothermally processed wheat were 
prepared in CERZOO feed mill, according to the experimental scheme. HPC was 
included in the basal diet as partial substitute of the wheat meal. The hydrothermally 
processed cereals were included as partial substitute of the wheat meal used in the 
control diet. No medication or AGP were included in the diets.  
The 6-wk trial included a prestarter period (2 wk) and a starter period (4 wk). Diets 
(Table 2) were slightly modified according to the requirements of the animals, but 
maintained constant levels of HPC. Animals had free access to feed and water.  
Piglets BW and feed intake were determined at 14 and 42 days after weaning to 
calculate ADG, ADFI, and F:G. Daily inspections were carried out by qualified 
personnel to check the general health status of piglets and presence of diarrhoea. 
 
  
 
Blood sampling 
On day 0, 14, and 42, six randomly-selected piglets for each pen (18 piglets in total, 3 
castrated male and 3 female per each treatment) were bled via vena cava puncture to 
obtain plasma samples for routine haematology and biochemistry analysis. According to 
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 the study protocol the blood samples were analysed also for haptoglobin. At the same 
time plasma EDTA samples were collected to determine intestinal fatty acid-binding 
protein (I-FABP) concentration, a parameter used to assess damage of the intestinal 
mucosa in pigs, which has been determined by using a human commercial ELISA test 
kit (HyCult Biotechnology BV, Uden, the Netherlands) as described by Niewold et al. 
(2004). 
 
Feed analysis 
 
Both processed and unprocessed wheat and complete diets were analytically 
characterised. HPC and W were assayed in duplicated according to AOAC (1990) for 
dry matter (procedure 930.15), crude protein (procedure 975.06), ash (procedure 
942.05) and acid detergent fibre exclusive of residual ash (procedure 973.18).  
Crude fat content was measured according to the indications of the Direction EEC n. 
84/4/EEC of 20.12.83 (G.U. EC L15 18/01/84), crude fiber was determined by the 
method of Wende (AOAC, 1990). Neutral detergent fibre was assayed with heat stable 
amylase with correction for residual ash according to Mertens (2002), without sodium 
sulphite and using Ankom device (Ankom 220, USA) for extraction and filtering. 
Samples starch content was determined by AOAC Polarimetric method (2000). Soluble 
sugars were determined according to AOAC method (1999). Soluble protein was 
quantified following the method described in Licitra et al. (1996), which gives soluble 
protein as the difference between the total content and the insoluble fraction. 
Digestible Energy was calculated according to Whittemore’s (1987) equation and Net 
Energy according to the equation of Noblet et al. (1994). 
 
Table 1. Analytical characteristics of the HPC vs commercial wheat (W), % as dry 
matter. 
 
  
HPC 
 
W 
Dry matter 94.61 87.45 
Crude Protein 11.48 13.95 
Crude fat 1.24 1.31 
Crude fiber 1.83 3.25 
Ash 1.48 1.44 
NDF 12.81 17.60 
ADF 3.44 3.46 
Starch 63.90 56.92 
Total Sugars 7.36 1.92 
 
 59
  Table 2. Diet composition (mash feeds). 
 
  Prestarter  
0-14 days 
Starter 
14-42 days 
Barley meal % 35.00 35.00 
Wheat meal % 36.16 37.52 
Soybean meal 46% % 6.88 11.75 
Forcital omega 1 % 5.00 5.00 
Corn meal % 5.00 5.00 
Milk whey, sweet dried % 5.00 - 
Potato protein % 2.00 - 
Soybean oil  % 1.36 1.98 
Calcium formate % 0.94 0.40 
Calcium carbonate % - 0.30 
Monocalcium 
phosphate 
% 0.65 1.37 
Fermix2 % 0.50 0.50 
Sodium chloride % 0.47 0.46 
L - Lysine HCL  % 0.61 0.45 
L – Threonine % 0.20 0.15 
DL - Methionine % 0.18 0.10 
L – Tryptophan % 0.05 0.01 
 
Notes: 1 – Forcital Omega is a combination of highly digestible vegetable protein 
sources processed with extrusion technology, and high quality salmon oil 
Notes: 2 - Vitamin and mineral premix (Adisseo Filozoo, Carpi, Italy) 
composition per kg of premix: vit. A: 4,166,500 IU; vit. D3: 479,190 IU, vit. E: 
9,523 mg; vit. B1: 595 mg; vit. B2: 1,190 mg; vit. B6: 714 mg; vit. B12: 7 mg; D-
pantothenic acid: 2,975 mg; vit. H: 35 mg; vit. K3: 952 mg; vit. PP: 4,760 mg; 
Folic acid: 119 mg; Co: 95 mg; Fe: 7,428 mg; I: 357 mg; Mn: 16,666 mg; Cu: 
39,285 mg; Se: 47 mg; Zn: 59,523 mg; carbonate of Ca and Mg to 1,000 g as 
excipient.  
 
 
Table 3. Analytical characteristics of the diets (% as dry matter). 
 
0-14 d  14-42 d 
 
 
CCTRL T2 T3 1CTRL T2 T3 
Digestible energy1, 
MJ/kg 16.06 16.06 16.07 16.01 16.00 16.03 
Net energy2, MJ/kg 11.02 11.92 11.93 11.78 11.79 11.80 
Dry matter, % 90.69 90.76 91.05 90.56 90.69 90.73 
Crude protein, % 19.18 19.22 19.28 19.41 19.15 18.94 
Crude fibre, % 4.24 4.59 4.25 3.86 4.20 3.45 
Crude fat, % 4.55 5.11 4.58 3.30 3.34 3.70 
Ash, % 5.78 6.06 5.75 9.96 10.02 9.62 
Starch, % 45.54 44.31 45.96 38.06 38.87 39.33 
Note: 1- According to Whittemore (1987); Note: 2- According to Noblet et al. (1994) 
Hydrolysis kinetics of cereals and complete diets  
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 Enzymatic starch digestibility with amylase was assessed following the modified 
%) and 5 ml of concentrate sulphuric 
s starch 
imetric method. 
ntent was measured with spectrophotometer at 510nm wave length. Digested 
of sample 
method of Mercier and Guilbot (1974). Briefly, 2.5 g of feed samples, ground with 
1mm screen, were put into 250 ml glass batches, and 97.5 ml of buffer solution 
(NaH2PO4 0.2 M and Na2HPO4 0.2 M) were added in each samples flask. The samples 
solutions were kept in the heat bath gently shaken for few minutes. At the scheduled 
time (0’, 30’, 90’, 120’ minutes from the beginning of the incubation) 3 ml of samples 
diluted in buffer enzymatic solution were collected. Samples were then transferred to 
centrifuge tubes with 13.5 ml of alcoholic-acetic solution and 2.5 ml of buffer solution 
containing 0.3% of amylase from porcine pancreas (Sigma A3176). The test tubes were 
frozen for 3 hours and then centrifuged. The supernatant (200 μl) was transferred into a 
glass vial and dried in a vacuum stove at 40°C.    
The pellet was resolved with 2 ml of phenol (2.5
acid, shaken in order to homogenise the sample and boiled for 8 min. Once cooled, the 
glucose content was measured with spectrophotometer at 510 nm wave length. 
Amyloglucosidase test (AGA test) was performed to evaluate sample
degradability due to amyloglucosidase activity. Dried and fine ground (1 mm screen) 
samples were weighted (1 g) into a 50 ml Erlenmeyer flask, and 25 ml of distilled water 
and 2.5 ml of acetate buffer pH 4.8 (16.4 g of sodium acetate and 12 ml of acetic acid 
dissolved in 100 ml of distilled water, pH adjusted with NaOH) were added to each 
sample, ensuring a good dispersion of the sample. After that 5 ml of amyloglucosidase 
(from Aspergillus niger; Fluka, 70 U/mg) distilled water solution (1%) were added to 
the sample’ solutions, which were then placed in 60ºC water bath for 1 hour.  Samples 
were mixed once in a while during the incubation time. After incubation, 0.5 ml of 
suspension was diluted in 9.5 ml of TCA 5% (trichloroacetic acid dissolved in distilled 
water), to allow protein precipitation and to block the enzyme activity.  
Samples were centrifuged and analysed for glucose content with a color
A 50 µl of sample were collected in a test tube and diluted in 3 ml of GODPOD 
(colorant reagent). At the same time a standard as well as a blank sample were prepared, 
as reference value and to correct the instrument readings for the analysis. Samples 
diluted in GODPOD were kept in the dark for 30 minutes, to allow the colorimetric 
reaction.  
Glucose co
starch was calculated following the formulas described below. 
(Sample Abs/STD Abs) x (6501/ Sample g) = mg of glucose/ g 
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 650= (32.5 dilution x 20 (10 ml/0.5)) 
 
In vitro digestibility starch and proteins of diets 
estigate the kinetics of diets starch 
gestibility of the diets was assessed following the Bedford and Classen 
pre-incubation, 5 ml of NaOH 1N and 5 ml of buffer solution (NaHCO3, 
wing the experimental protocol, at the end of the incubation time, 1 ml of the 
ed at 6 and 24 h from the beginning of the in vitro 
were first extracted with dilute hydrochloric acid (0.1 N). The co-extracted 
Diets samples were digested in vitro to inv
degradation and the amount of free amino acids released after 6 and 24 hours of 
digestion. 
In vitro di
method (1993) as described by Stevnebø et al. (2006). To simulate gastric conditions, 
500 mg of dried ground feed were pre-incubated in 5 ml of HCl 1M and pepsine (50 g/l, 
pH 1.5; Merck, Darmstadt, Germany) in a heat bath with a swirly system at 39°C for 30 
minutes.  
After the 
adjusted to pH 6-6.5 with H3PO4), 25 ml of enzymatic buffer containing 25mg of 
pancreatin (300 U α-amylase/mg porcine pancreatin; Sigma Aldrich Co, St. Louis, 
USA) and 25 mg amyloglucosidase (from Aspergillus niger; Sigma Aldrich, 70 U/mg), 
dissolved in distilled water, were added to each sample to obtain a final volume of 40 
ml. 
Follo
solutions was transferred into an eppendorf tube and placed in a boiling water bath for 2 
min to stop the enzymatic reactions. After centrifugation, 50 µl of sample were 
collected and diluted in 3 ml of colorant reagent. At the same time were prepared a 
standard as well as a blank sample, as reference value and to correct the instrument 
readings for the analysis. Glucose concentration and digested starch were determined as 
previously described in the text.  
Free amino acids were determin
degradation. 
Amino acids 
nitrogen molecules were precipitated with picric acid and removed by filtration through 
a resin column. The filtered solutions were adjusted to pH = 2.20. The amino acids were 
separated by ion exchange chromatography and determined by reaction with ninhydrin, 
with photometric detection at 570 nm (G. U. L272/14 19/09/98). 
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 Statistical analysis 
Average daily gain, average daily feed intake and F:G were analyzed by the Tukey-
Kramer test using the GLM procedure of SAS 9.1 (SAS Inst. Inc., Cary, NC). The pen 
was used as the experimental unit and initial BW as a covariate. The linear or quadratic 
effects were not tested due to the low number of treatments. Blood parameters were 
analysed by the Tukey-Kramer test and the GLM procedure of SAS 9.1 (SAS Inst. Inc., 
Cary, NC), using the initial values as covariate. 
 
 
Results 
 
Growth performance 
During the trial there were no mortalities and none of the piglets showed signs of 
diarrhoea or needed to be removed for poor performance or health reasons. Results for 
BW, ADG, ADFI, and F:G ratio are shown in Table 4. 
Significant differences were found among feeding treatments for final body weight and 
average daily gain. In piglets fed the diet with 6% of HPC supplementation there was a 
significative improvement in ADG (P= 0.014) during both growth phases. Average 
daily feed intake was not affected (P> 0.05), even if it tended to be higher during the 
second growing period and in the whole experiment in T2 and T3 groups. Feed 
conversion rate improved in T3 during the 0-14 days period and the whole experimental 
period (P= 0.051 and P= 0.053). 
Final BW was higher in T2 and T3 groups compared to T1 (P< 0.05). Pigs fed the diet 
with the highest HPC supplementation had lower F:G (P< 0.05) during the prestarter 
period and during the whole experimental period. 
 
Blood parameters 
As shown in the Tables (6-9) there were no main effects of feed treatments on 
haematological and biochemical parameters. A significative difference was found only 
in blood calcium level at 14 and 42 days, where the values were higher in the control 
group piglets (P= 0.026 and P= 0.021, respectively).  
At 42 days, bilirubin tended to be lower (P= 0.062) while concentration of uric acid 
increased in pigs fed the diet with HPC supplementation (P= 0.065). Uric acid is a  
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 Table 4. Effect of specially processed cereals on growth of weaned piglets. 
 
Level of hydrothermally processed 
wheat Effect of  
 0% 3%  6% 
 
SEM 
Treat Sex Sex * Treat 
Initial BW, Kg 6,35  6,35  6,36  0,13 0,997 0,075 0,778 
Final BW, Kg 21,08 b 21,52 ab 22,22 a 0,32 0,018 0,082 0,332 
ADG, g/d        
0-14 d 310 b 320 ab 339 a 8,16 0,014 0,685 0,286 
14-42 d 372 ab 370 b 397 a 7,37 0,026 0,014 0,501 
0-42 d 351 b 353 b 378 a 6,82 0,003 0,097 0,400 
ADFI, g/d        
0-14 d 452  450  450  4,58 0,937 0,680 0,276 
14-42 d 552  587  582  10,93 0,063 0,175 0,820 
0-42 d 519  540  538 7,15 0,079 0,208 0,602 
Feed:Gain        
0-14 d 1,47 a 1,42 ab 1,34 b 0,04 0,051 0,741 0,139 
14-42 d       1,50                   1,59     1,47  0,04 0,147 0,471 0,681 
0-42 d 1,48 ab 1,58 a 1,43 b 0,04 0,053 0,656 0,606 
 
ADG: average daily gain;  ADFI: average daily feed intake; 
a,b Means with different superscript significantly differ (P< 0.05). 
 
 
product of the metabolism of purine bases, high values in plasma might be related to a 
higher protein turnover in animal with a faster growth.  
Plasma I-FABP was monitored to assess the health status of the intestinal epithelium 
during the post-weaning period. Feeding treatments did not influence the I-FABP 
plasma concentration and, as expected by the good health of the animals, the values 
were low, in the range 61.6-77.1 pg/ml (Table 5).  
Plasma I-FABP concentration decreased during the trial in all groups, with significative 
differences between groups. It is noteworthy that in T2, plasma I-FABP decreased 
significantly in the first 2 weeks after weaning. At the end of the trial, the lower values 
were detected in the HPC fed animals.  
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Table 5. Blood levels of I-FABP in piglets fed diets supplemented with increasing 
amount of specially processed cereals.  
 
Days of growth 
Treatment 
0 14 42 
Time Effect 
Control diet 77.10b 68.58ab 63.61a 0.0163 
3% HPC 75.49c 61.59b 63.80a 0.0210 
6% HPC 77.05b 67.47ab 62.14a 0.0308 
SEM 3.448 3.009 1.421  
     
Treatment 0.932 0.301 0.684  
Sex 0.461 0.975 0.108  
T * S 0.085 0.062 0.342  
  a,b,c P<0.05
 Table 6. Effect of hydrothermally processed cereals on blood parameters in weaned piglets after 14 days of growth. 
 
Blood parameters  Level of treated cereals.  Effect of: 
0% 3% 6% SEM Treatment Sex S * T 
Haematocrit                l/l 0.343 0.334 0.313 0.0101 0.130 0.518 0.939 
Glucose                       mmol/l   6.13 5.84 5.42 0.2239 0.134 0.837 0.267 
Urea                            mmol/l 5.87 5.78 5.82 0.3478 0.319 0.915 0.896 
Cholesterol                 mmol/l 2.16 1.97 2.30 0.1580 0.375 0.520 0.910 
Triglycerides             mmol /l 0.39 0.36 0.32 0.0408 0.209 0.615 0.228 
Phospholipides      mg/100ml 109.17 104.00 108.45 7.1764 0.860 0.666 0.720 
Creatinine                   μmol/l 88.62 83.17 91.73 3.2767 0.215 0.556 0.028 
Uric acid                       mg/dl 0.082 0.098 0.072 0.0154 0.501 0.168 0.876 
Bilirubin                      μmol/l 1.52 1.02 1.24 0.2163 0.297 0.491 0.858 
LDH                              U/l  1323.94 1246.71 1369.02 56.35 0.334 0.963 0.279 
Aptoglobine                  g/l 2.38 2.60 2.12 0.1997 0.662 0.527 0.177 
GOT                              U/l 46.78 50.94 49.46 5.2492 0.853 0.808 0.547 
GPT                               U/l 54.50 52.06 46.74 4.6925 0.509 0.325 0.933 
Alkaline phospatase     U/l 330.25 33.59 292.11 25.2088 0.457 0.622 0.305 
Ca                               mmol /l  2.70b 2.56a 2.64ab 0.0288 0.026 0.831 0.510 
P  mmol /l 3.34 3.31 3.23 0.0859 0.668 0.154 0.534 
 
SEM = Standard error of means. 
a,b Means with different superscript significantly differ (P<0.05).
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 Table 7. Effect of hydrothermally processed cereals on blood parameters in weaned piglets after 42 days of growth. 
 
 Blood parameters Level of treated cereals.  Effect of: 
0% 3% 6% SEM Treatment Sex S * T 
Haematocrit                l/l 0.333 0.30 0.23 0.0085 0.535 0.065 0.292 
Glucose                       mmol/l   6.30 6.45 5.64 0.4871 0.481 0.632 0.272 
Urea                            mmol/l 6.69 6.84 6.23 0.3599 0.594 0.881 0.929 
Cholesterol                mmol/l 2.37 2.43 2.37 0.1209 0.913 0.799 0.983 
Triglycerides              mmol /l 0.309 0.314 0.284 0.0416 0.825 0.772 0.964 
Phospholipides     mg/100ml 130.24 130.44 123.76 5.8176 0.662 0.522 0.258 
Creatinine                   μmol/l 89.89 88.55 86.16 2.9967 0.951 0.616 0.043 
Uric acid                       mg/dl 0.0833 0.1062 0.1699 0.0241 0.065 0.544 0.664 
Bilirubin                     μmol/l 0.862 0.496 0.286 0.1552 0.0621 0.293 0.875 
LDH                              U/l  1294.04 1343.22 1471.27 62.359 0.159 0.908 0.277 
Aptoglobine                  g/l 1.33 1.48 2.22 0.2584 0.605 0.685 0.721 
GOT                              U/l 50.34 50.92 62.79 6.8580 0.380 0.392 0.278 
GPT                               U/l 57.64 70.42 65.29 5.389 0.279 0.873 0.777 
Alkaline phospatase     U/l 180.94 213.92 180.79 19.329 0.405 0.279 0.296 
Ca                              mmol /l  2.90b 2.77ab 2.75a 0.0352 0.021 0.842 0.235 
P  mmol /l 3.72 3.68 3.57 0.1039 0.582 0.863 0.206 
SEM = Standard error of means
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 Table 8.  Blood parameters: haematology after 14 days from the start of the study. 
 
   
TCTRL 
 
T2 
 
T3 
 
Effect of 
treatment 
 
 
SEM 
WBC – leucocytes K/Ul 16.20 11.64 14.82 0.145 1.5771 
RBC – erythrocytes M/Ul 5.45 5.28 5.47 0.512 0.1242 
HGB – Haemoglobin  g/dl 10.62 10.27 10.54 0.650 0.2743 
HCT – Haematocrit % 32.00 31.03 32.58 0.515 0.9401 
MCV 1  fL 58.97 58.80 59.47 0.942 1.4162 
MCH 2 pg 19.58 19.42 19.30 0.901 0.4404 
MCH 3 g/dl 33.22 33.07 32.43 0.465 0.4633 
RDW  % 26.63 23.58 26.22 0.268 1.3791 
PLT – platelets K/Ul 582.50 589.83 498.22 0.693 83.1422 
Neutrophilis % 48.80 63.00 54.82 0.237 5.6590 
Lymphocytes % 45.00 31.00 37.42 0.287 6.0128 
Monocytes % 4.36 4.38 5.53 0.569 0.8762 
Eosinophilis % 1.60 1.50 2.04 0.591 0.3866 
Basophils % 0.22 0.13 0.21 0.598 0.0651 
 
 
Table 9.  Blood parameters: haematology after 42 days start of the study. 
 
   
CTRL 
 
T2 
 
T3 
 
Effect of 
treatment 
 
 
SEM 
WBC – leucocytes K/Ul 20.67 20.87 20.45 0.9894 2.0156 
RBC – erythrocytes M/Ul 6.00 5.73 5.90 0.6805 0.2196 
HGB – Haemoglobin  g/dl 10.30 10.06 9.98 0.6734 0.2593 
HCT – Haematocrit % 31.57 30.77 31.52 0.7734 0.8765 
MCV 1  fL 52.65 53.72 53.65 0.6364 0.8755 
MCH 2 pg 17.20 17.57 17.00  0.4247 0.3017 
MCH 3 g/dl 32.70 32.70 31.70 0.1988 0.4300 
RDW  % 21.88 b 20.62 a 22.55 b 0.0087 0.3817 
PLT – platelets K/Ul 437.50 406.17 476.67 0.7433 64.2149 
Neutrophilis % 37.22 32.45 42.78 0.3998 5.2375 
Lymphocytes % 56.20 59.55 50.03 0.5227 5.8639 
Monocytes % 4.75 5.83 4.97 0.6767 0.8985 
 
Eosinophilis % 1.48 1.42 1.69 0.8718 0.3826 
Basophils % 0.33 0.76 0.54 0.1315 0.1422
MCV1 : mean corpuscular volume 
MCH2 : mean content of haemoglobin / erythrocytes 
MCHC3 : mean globular concentration of haemoglobin  
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 In vitro hydrolysis kinetics 
Total sugars determination and in vitro enzymatic hydrolysis evidenced the higher 
availability of sugars in HPC compared to unprocessed wheat, likely due to the 
hydrothermal process.  
Determination of soluble sugars content of the samples by HPLC, showed that HPC 
contained 6.96% of sugars compared to 1.92% of control wheat (Table 11). 
In vitro rate of starch hydrolysis by α-amylase (from porcine pancreas), performed on 
the wheat kernels (HPC and W), measured after 0, 30, 90 and 120 minutes of 
incubation, was higher in the hydrothermally processed wheat, during all the time 
course of the experiment (Figure1). Indeed at the beginning of the incubation 11.74% of 
HPC starch was already hydrolysed to mono and oligosaccharides.  
The kinetics of in vitro hydrolysis by α-amylase of experimental diets is shown in 
Figure 2. At time 0, the degree of hydrolysed starch was similar between diets. During 
the first 30 minutes of enzyme treatment, the rate of starch degradation was similar for 
T1 and T2, while T3 diet, which had the highest HPC level of inclusion, showed a 
higher rate. The same trend was observed after 90 minutes of incubation. Between 90’ 
and 120’, the degree of starch hydrolysis was improved in both T2 and T3 diets (Figure 
2).  
 
Table 10. Soluble sugars determination in hydrothermally processed wheat (HPC) and in 
commercial wheat (W) assessed by  HPLC. 
 
 Sugars % HPC W 
Fructose  0.24 
 
0.11 
Glucose 2.70 
 
0.62 
Sucrose 0.73 
 
0.57 
Maltose 4.86 
 
1.19 
Lactose 0.23 0.05
 
 
In vitro starch degradation by amyloglucosidase (AGA test) showed that after 1 hour of 
incubation more than 60% of starch contained in HPC was degraded, compared to 25% 
of the control wheat (Figure3). Hydrolysis of diets by AGA test showed that 13.82% of 
T1 starch was degraded after 60’, compared with 23.39% and 23.72% of T2 and T3. 
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 Figure 1. In vitro rate of starch hydrolysis by α-amylase in HPC and W wheat kernels 
measured at incubation time 0, 30, 90 and 120 min. 
 
 
 
 
 
 
Figure 2. In vitro rate of starch hydrolysis by α-amylase of the experimental diets 
measured at incubation time 0, 30, 90 and 120 min. 
 
  
In vitro digestibility of the prestarter and starter diets by porcine pancreatin and 
amyloglucosidase was performed to assess the amount of essential amino acids released 
during digestion by the different diets (Table 6). After 6 and 24 hours of enzymatic 
treatment, both prestarter and starter T2 diets showed the highest level of digested 
proteins and released free essential amino acids. Among the prestarter diets, at 6 h the 
amount digested starch was higher in T3 diet.  
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 Figure 3.  Degree of starch digested by amiloglucosidase of wheat kernels and 
experimental diets at 60 minutes. 
 
 
 
 
At 24 h, the T3 diets had the highest level of free amino acids and digested protein, 
while T2 had the highest amount of digested starch. 
 
 
Table 11. Starch and protein digested and essential aminoacid released after 6 and 24 h 
of in vitro digestion of the experimental diets. 
 
Diets digestibility 6hours  Diets digestibility 24hours 
 Starch 
digested 
% 
CP 
digested 
% 
Free EAA 
% 
Starch 
digested 
% 
CP 
digested 
% 
Free EAA 
% 
Prestarter       
T1 31.14 54.88 4.88 53.31 72.70 6.47 
T2 26.35 56.50 5.11 65.24 71.12 6.34 
T3 33.06 49.60 4.66 66.39 72.72 6.67 
Starter       
T1 24.15 49.35 4.43 53.31 72.57 6.61 
T2 25.95 58.02 5.22 63.75 75.37 6.73 
T3 37.88 57.44 5.10 57.47 76.32 6.84 
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 Figure 4.  Starch digested at 6 and 24 h of in vitro experimental diets digestion. 
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 Discussion and Conclusions 
 
Early weaning exposes piglets to simultaneous nutritional, social and environmental 
stresses that can lead to an impairment of health status and to a major susceptibility 
towards infections (Hiss and Sauerwein, 2003). Moreover, gastrointestinal diseases 
around weaning occur in a context of incomplete development of the digestive and 
immune systems physiology (Partanen and Mroz, 1999). Up to 2006, the use of 
antibiotics seems to have been the most effective way to control the negative effects of 
premature weaning on animal health and performance. Immuno-modulatory feed 
additives could be the alternative to AGP in livestock production by improving the 
animals’ natural ability to fight diseases (Gallois et al., 2009). 
According to Lange and Lönnroth (2001), feeding hydrothermally processed cereals can 
induce endogenous secretion of the AF protein in both human and animals. AF-inducing 
diets improved intestinal fluid balance and inflammation in patients affected by 
inflammatory bowel diseases (Björck et al., 2000). Improved intestinal fluid balance 
and growth performance in animals fed AF-inducing diets were reported by Göransson 
(1993) and Lange and Lönnroth (2001). 
During this trial, none of the piglets showed signs of diarrhoea. This was not 
unexpected, given the experiment was conducted in an experimental facility where 
pathogens presence might be generally lower than on a commercial farm. 
Supplementation of the wheat-barley based diet with 6% of HPC improved the average 
daily gain (P= 0.003) and the feed conversion rate during the whole experimental period 
(P= 0.053). Feed intake was higher in both T2 and T3 groups, compared to the control, 
during the second growing phase, even if the differences were not significative (P= 
0.063). There were no significative effects of feed treatment on blood parameters. At 42 
days, a higher amount in plasma level of purine metabolites, as uric acid, was found in 
piglets fed T3 diet (P= 0.065), likely due to a higher protein turnover in fast growing 
piglets. At the end of the trial, total serum bilirubin tended to be lower in the HPC-fed 
groups (P= 0.062), though bilirubin is correlated to heme turnover and high values are 
correlated to several hepatic diseases, the values were low and into the range of the 
reference for pigs (Kaneko, 1997).  
Plasma I-FABP can be considered as an indicator of gut mucosa damage. It is found 
only in the mature enterocytes of the small intestine, with only trace amounts identified 
in the stomach and large intestine, and it can be detected in plasma and urine after cell 
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 damage (Niewold et al., 2004). Reduction of the intestinal oxygen supply in pigs, as a 
way to induce metabolic stress to the intestinal mucosa, was previously shown to induce 
intestinal cells damage and increase plasma I-FABP concentrations (Niewold et al., 
2004). In the current study the concentration of I-FABP in plasma were low in all 
groups and not affected by the dietary treatments, suggesting that, in good hygienic 
conditions, the dietary treatments did not affect small intestinal integrity. On average, I-
FABP levels were numerically less in piglets 6 wk after weaning compared with 2 wk 
after weaning. However we did not detect significant differences in the plasma I-FABP 
level between diets, so it is not possible to clarify if the better performance observed in 
piglets fed the 6% HPC supplemented diet might be due to an anti-inflammatory affect 
of the endogenous antisecretory factor possibly induced by the HPC inclusion in the 
diets.  
The difference in growth performance observed in this study between might be in part 
related to a balanced supply of energy-yielding nutrients and amino acids in the diets.  
Starch in cereals has a great importance in newly weaned piglets since it constitutes the 
largest portion of the diet and is the major energy-yielding component (White et al., 
2008). The larger part of starch is digested in the upper part of the small intestine. 
Starch which is not digested in the small intestine will enter the large intestine and will 
be fermented (Cummings and Englyst, 1995). Starch digestibility is related to the source 
and processing of the starch (Graham et al., 1989; van der Poel et al., 1992). According 
to Wiseman (2006), the rate of starch digestion is a crucial characteristic that rules the 
dietary energy value of compound diets. As expected, the in vitro digestion assays 
evidenced a relevant simple sugars content and a higher rate of starch hydrolysation in 
the hydrothermal process wheat compared to the unprocessed cereal (Figure1). 
Inclusion of HPC (6%) as partial substitute of unprocessed wheat meal resulted in a 
higher in vitro starch digestion rate of T3 diet but not in T2, where the inclusion level 
used was 3% (Figure 2).  
According to Van den Borne et al. (2007), pig performance is maximized when the 
absorption of energy-providing nutrients and amino acids, for protein synthesis, is 
synchronized.  
After 6 hours of in vitro enzymatic digestion of the diets T2 (3% HPC) showed the 
highest amount of digested protein and free amino acids, associated to a lower diet 
starch digested.   
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As reported by Cummings and Englyst (1995), a decrease in the rate of starch digestion 
may reduce or delay the postprandial glucose and insulin responses. The slower rate of 
starch digested in T2 diet might have reduced the amount of glucose available for the 
intestinal tissue metabolism, leading to an increased gluconeogenesis and to a reduced 
amount of amino acids for protein deposition.  
According to Lallès et al. (2004), cooked cereals are thought to improve post-weaning 
performance because the starch is more gelatinised and hence they assist in overcoming 
the (temporary) period of pancreatic amylase insufficiency that generally occurs after 
weaning. The first week after weaning is characterized by reduced feed intake and 
reduced pancreatic enzymes activity. Therefore feeding a diet with highly digestible 
starch guarantees a correct amount of energy, limiting the amount of feed to be 
fermented in caecum and colon.  
 
 
 In vitro assessment of the antisecretory activity of AF-
16 
 
 
The Ussing Chamber 
The Ussing chamber method was developed in the 1950s by the Danish biologist Hans 
H. Ussing as a means to understand the phenomenon of active NaCl transport across 
epithelium.  
The first model system was the frog skin because of its ability to move NaCl from the 
skin surface into the interstitium against more than a 100-fold concentration difference 
(Clarke, 2009). To distinguish the active ions transport from the passive diffusion 
through paracellular and intercellular pathways across the epithelium, dissected frog 
skin separated two halves of a chamber, each of which were perfused with identical 
electrolyte solutions. Therefore, paracellular ion movements driven by osmotic and 
electrochemical gradients were eliminated. The passive transepithelial driving force, 
created by the spontaneous electrical potential across the epithelium, was eliminated by 
clamping the potential to zero with an external current passed across the epithelium 
(Clarke, 2009). This current, known as the short-circuit current (Isc), is equivalent to the 
algebraic sum of electrogenic ion movement by active transport. Consequently, 
eliminating transepithelial diffusion forces, the movement of ions as measured by Isc in 
the Ussing chamber resulted from active transport (Clarke, 2009). 
Nowadays, the Ussing chamber method is applied to every epithelium of the animal 
body and is extensively used for studies on cultured epithelial cells where tight junction 
integrity maintains apical and basolateral membrane polarity.   
Ussing chamber studies of intestinal mucosa improved the understanding of 
transepithelial transport processes toward a molecular basis. Indeed, the Ussing 
chamber technology allows a direct contact between the tissue and the substances 
studied, provided these substances are soluble and it is time-proven method for the 
measurement of electrolyte, nutrient and drug transport across epithelial tissues (Clarke, 
2009). As reported by Boudry (2005), the Ussing chamber is a valid method to measure 
the active ion transport across the intestinal mucosa and study its permeability, which 
are relevant parameters to assess gut health.  
Moreover, this method allows to study the effects of substances whose antisecretory 
activity is suspected and to clarify their mechanisms of action. 
 77
 The intestinal fluid secretion 
Fluid secretion plays a key role in the gut physiology since it is required for hydration 
of the intestinal mucosa and mixing of intestinal contents. Under normal conditions, the 
intestine carries out the absorption of luminal fluid, electrolytes and nutrients. Several 
channels and cotrasporters regulate the ionic balance on both sides of the intestinal 
epithelium. Water and solute absorption is mainly realized by Na+/glucose, Na+/K+, Cl-
/HCO3- exchangers (Lapointe et al., 2009). At the apical side, cAMP-dependent cystic 
fibrosis transmembrane conductance regulator (CFTR) is fundamental to create the 
osmotic gradient that drives the passage of water into the lumen. Fluid secretion is 
driven by active Cl- transport from the basolateral to the apical side of enterocytes: Cl- is 
taken up at the basolateral membrane via NaK2Cl cotransporter, which is driven by Na+ 
and Cl- concentration gradients produced by the Na+K+-ATPase and basolateral K+ 
channels. Cl- is electrochemically driven across the cell apical membrane primarily 
through the CFTR, as well as through Ca2+-activated Cl- channels (CaCCs) and other 
Cl- channels. Both Na+ and fluid follow Cl- paracellularly. During gastrointestinal 
diseases, regulatory mechanisms of secretion are altered. Inflammation and diarrhoea, 
caused by either infectious or non infectious etiologies, are the result of changes in fluid 
and electrolytes transport in the small and/ or large intestine (Fordtran, 1967). 
Escherichia coli and Vibrio cholera are among the major agents causing diarrhoea in 
both human and animals. Bacteria enterotoxins induce secretory diarrhoea by improving 
active transport of anions, mainly chloride and bicarbonate, from crypt epithelial cells. 
Thus, a key player in the response to enterotoxin-induced intestinal fluid secretion is the 
apical anion channel CFTR. 
Cholera toxin (CT) induced diarrhoea has been considered a prototype of enterotoxin-
caused diarrhoea, because it does not cause histological changes in the intestine despite 
substantial rates of net fluid secretion (Field et al., 1972). CT attaches the enterocytes 
by binding to GM1-ganglioside via the B-subunit and the binding itself triggers the 
toxin internalization. Into the cell, CT increases cAMP level (Moss et al., 1981). CT and 
the increased cAMP stimulate active Cl- secretion by activating or inserting Cl- channels 
into the apical membrane of the crypt cells, and inhibit electroneutral NaCl absorption 
by decreasing the activity of apical membrane Na+/H+ and Cl-/HCO3- exchange in 
villous cells, without interfering with the glucose stimulated Na absorption (Petri et al., 
2008). Moreover, CT induces diarrhoea by an indirect pathway which involves the 
enteric nervous system, by inducing the secretion of neurohormones as 5-HT (5- 
 78
 hydroxytryptamine) and vasoactive intestinal peptide (VIP) (Cooke et al., 1994; 
Cassuto et al., 1981).  
The antisecretory properties of AF has been evaluated in both rat and pig intestinal loop 
models challenged with several secretagogues such as bacterial enterotoxins and 
intestinal neurohormones.  
The antisecretory activity of three AF-derived peptides (A1, A3 and A4), overlapping 
the antisecretory and anti-inflammatory domain of the complete protein, was evaluated 
in in vivo and in vitro studies (Grøndal et al., 2002). In the in vivo experiments on pig 
intestinal loops, A3 showed to have the highest antisecretory activity and reduced by 
60% the CT-induced fluid accumulation in the proximal small intestine. It also reduced 
by 60% LT-induced hypersecretion in the proximal and distal intestinal loops, while no 
effect were seen on 5-HT challenged loops.  
The antisecretory properties of A3 were also evaluated by electrophysiological 
experiments performed on pig intestinal mucosa, stripped of outer muscle layers, in an 
Ussing chamber trial. The peptide (10 nmol/l) was added bilaterally 30 minutes before 
the challenge with secretagogues, including substance P, VIP, 5-HT and theophylline 
which were added to the serosal side of the tissues. A3 had no effect on the 
secretagogues-induced increase of short circuit current (Isc). Grøndal and colleagues 
(2002) suggested that the antisecretory effect of AF-derived peptides involves the 
neuronal structures of the intestinal mucosa. It has been suggested that AF might 
attenuate the secretory reflexes in the enteric nervous system (Kim et al., 2005).  
However, the pathway for the antisecretory effect of AF is not yet clear. Flotillin-1, an 
integral protein localized in the lipid rafts, was recently identified as an interacting 
protein for antisecretory factor (Johansson et al., 2008). Both CT and AF receptors 
seem to be localized in the lipid rafts, specialized cell membrane area with a high 
concentration of receptors and ion channels. Johansson et al. (2008) suggested that 
cytoplasmatic AF can modulate the signal pathway of CT by interacting with flotillin-1. 
This in turn might affect the localization of signal proteins in the lipid rafts. On the 
other hand, exogenous addition of AF or AF peptides reproduced the effects of 
endogenous AF in many systems, indicating the presence of interacting structures 
exposed on the external part of the plasma membrane.  
The antisecretory effect of AF-16 was evaluated using an in vitro model of CT-induced 
hypersecretion measured electrophysiologically in IPEC-2J cells.  All the experiments 
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 were performed at Katholieke Universiteit of Leuven, Belgium, under the guidance of 
prof. T.A. Niewold. 
 
 
Materials and Methods 
 
Cell culture 
Intestinal porcine epithelial cell line (IPEC-J2, derived from newborn unsuckling piglet 
jejunum) were cultured in Dulbecco Modified Eagle Medium (DMEM)/ Ham’s F-12 
(1:1) medium supplemented with 5% fetal bovine serum, 1,6 % sodium bicarbonate, 1,5 
% HEPES, 0.5% sodium pyruvate and 1% antibiotic-antimycotic and incubated at 37°C, 
in 5% CO2 atmosphere. Medium was refreshed every 3 days and the cultures were split 
weekly.  
IPEC-J2 cells were seeded (6x105 cells/ml) on permeable Transwell-col inserts 
(Collagen-Coated membranes; 0.4 μm pore size, 1.12 cm2, 12 mm diameter, Corning 
Inc., Corning, NY) which were placed in 12-well plates. Once seeded on a permeable 
filter, the cells polarized and attached themselves to each other by forming tight 
junctions thus developing an epithelial structure. The culture medium was changed 
every 3 days at the luminal side (500 μl) and serosal side (1500 μl). To ensure that the 
monolayers exhibited the properties of a tight biological barrier, confluence was 
measured by checking trans epithelial electrical resistance (TEER) using an epithelial 
voltohmmeter (EVOM). Confluence, on average, was reached after 9-10 days of 
culture. 
 
 
 
 
 
 
 
 
    Figure 1. Transwell Plate (Corning Inc., Corning, NY). 
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 Reagents 
AF-16 peptide (VCHSK TRSNP ENNVG L, m.w. 1754.95), synthesized by ordinary 
solid phase technique, was generously provided by Prof. Stefan Lange of the Göteborg 
University (SW).  
The peptide was carefully dissolved to a concentration of 1 mg/ml in MilliQ water 
(57x10-5 M), divided into aliquots of 50 μl and stored at -20°C until use. The molar AF-
16 concentration used to perform the electrophysiological assays was 5.7x10-4M.  
The Ussing chamber experiments were performed using the HEPES-buffered Krebs-
Ringer’s solution (K-R) containing (in mM): 115 NaCl, 1.2 MgCl.6H2O, 5.9 KCl, 2.5 
CaCl2.2H2O, 26.1 HEPES buffer and 10.0 D-glucose. All chemicals were purchased 
from standard sources and were generally of the highest purity available. The HEPES-
buffered Krebs-Ringer solution was prepared fresh for each experiment and osmolality 
was measured by an osmometer (Vapor Pressure Osmometer 5500 WESCOR) and 
adjusted to 320 mosmol/kgH2O with saccharose, pH 7.4 at 37°C. 
Purified cholera toxin (Sigma) was first diluted in MilliQ water and after in Ringer-
Krebs solution used to do the tests.  Diphenylamine 2-carboxylic acid (DPC, Sigma) 
diluted to a stock solution and used at 2mM in all Ussing chamber experiments. 
 
Apparatus 
The electrophysiological measurements were performed in modified Ussing chambers 
apparatus designed by Prof. Dr. Willy Van Driessche (KU Leuven, Belgium).  
                                                                      
The chamber was shaped to host a transwell 
insert  (A = 1.12cm2) and was provided with 
holes for the electrodes. The monolayer 
divided the chamber in two compartments 
representing the apical side and the 
basolateral sides of the membrane.  
Both compartments of the Ussing chamber 
were continuously perfused by the bathing 
solutions, aerated with 95% O2/5% CO2 by 
a gas lift system. The solutions were pumped 
in and out the chamber from beakers via 
polyethylene tubes. In order to ensure a 
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 proper seal, the edges were coated, with a layer of silicone grease. During the 
experiments, the chamber and the solution were placed inside a close scaffolding, kept 
at 37°C. The short-circuit current (Isc) was recorded continuously using salt bridges 
(KCl 3M) and Ag/AgCl electrodes, and a multichannel computer- controlled voltage-
clamp unit. The silver chloride electrodes which measured the voltage were applied so 
that the tips were close to the monolayer. The tips of electrodes which measured the 
current were at around 15 mm from the epithelium. 
 
Electrophysiological measurement of net electrogenic transport 
The transwell insert containing an IPEC-2J cells monolayer was mounted into the 
Ussing chamber. The exposed surface area of the monolayer was 1.12 cm2. After that, 
the electrodes were inserted in the proper position and the chamber was placed inside 
the scaffold, heated at 37°C. To help maintain adhesion of the monolayer to the insert’s 
membrane, the apical and the basolateral compartment were carefully filled with the 
Krebs-Ringer solution by the means of polyethylene tubes and syringes. Attention was 
paid to avoid air bubbles close to the electrodes tips. Once the chamber was filled with 
the bathing solution, the pump for the inflow and outflow of the solutions was activated. 
Then, the Ag/AgCl electrodes were connected to automatic voltage clamp apparatus, 
realized by Prof Van Driessche. The voltage was clamped to zero and the short-circuit 
current (Isc) was continuously recorded as a measure of net active ion transport across 
the monolayer. Chamber fluid resistance was automatically subtracted. The 
transepithelial short-circuit current was continuously 
and simultaneously recorded (ImpDsp1.4; KU 
Leuven) and analyzed with Origin 7.0 software 
(Origin Lab, Northampton, MA).  An initial series of 
experiments were performed to characterize the effect 
of different dosage of cholera toxin (0.02, 0.1 and 1 
μg/ml) on Isc and evaluate the proper concentrations 
and duration of the experiment. After ~ 20 min of 
equilibration period to achieve a steady-state of Isc, 
CT was added at the bathing solution at the apical 
side; the concentration tested were To evaluate the in 
Figure 3. Ussing chamber apparatus 
used to perform the in vitro trials at the 
Department of Biosystems, Katholieke 
Universiteit of Leuven, Belgium.
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 vitro antisecretory property of AF-16 (5.7x10-4 M), it was added before or after CT (1 
μg/ml) at the apical or basolateral side. DPC (2 mM) was added at the apical side, 
according the experiment schedule. 
 
Data Analysis and Statistics 
The secretory responses were calculated as the difference between the basal Isc and the 
maximal effects (Δ Isc). Values for Isc were normalized per cm2 exposed area. The 
number of experiments represented independent measurement on separate monolayers. 
Comparisons between groups of data were made by Student t-test (MiniTab Release 
14.1). Treatment effects were considered significant at P < 0.05. 
 
 
Results  
 
Basal values of Isc were collected before the addiction of the toxin and AF- 16. In basal 
conditions, IPEC-2J cell monolayers maintained an Isc of 5.68 ± 0.03 μA/cm2 (mean ± 
SE, n= 15).  
Effects of CT on Isc. Different cholera toxin concentrations (0.02 to 1 μg/ml) were 
screened to evaluate the dose response, (Table 1). Once added to the apical bathing 
solution, CT induced a concentration-dependent increase of basal Isc. After a period of 
lag phase, that lasted about 30 minutes for all toxin concentrations used, Isc increased 
slowly, the highest value and the plateau were reached around 90 minutes after the 
beginning of the toxin treatment, (Figure 4). CT-induced secretory response was dose 
dependent and reached a value of Δ Isc= 5.60 μA/cm2 (n=6) at the highest concentration 
(1 μg/ml). 
 
Table 1. Secretory responses as changes of Isc (μA/cm2) evoked by different CT 
concentrations. 
CT concentration (1 μg/ml)   
 Isc  μA/cm2 0.02 0.01 1 
Max 8.911 9.643 10.304 
Min 5.089 5.340 4.696 
Δ Isc 3.821a 3.802a 5.607b 
Time Max (min) 91 96 90 
a, b P<0.001 
 83
 Figure 4. Effects of CT (1 μg/ml) added to the apical side of the chamber on Isc in 
IPEC-2J cells. 
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 Figure 5. Effects of AF-16 (5.7x10-4 M) added to the basolateral side of the chamber. 
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Effects of AF-16 on Isc. The AF-16 concentration (5.7x10-4 M) used to perform the 
tests was considerably higher than that used by Grøndal (2002). However, the peptide 
(A3) used by Grøndal and colleagues had a different aminoacids sequence, though it 
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 overlapped the active region of the protein (AF-16) and, used at nanomolar 
concentration, it was unsuccessful on reducing different secretagogues-induced Isc 
increase. Observations of the in vitro tests done to assess the AF-16 anti-inflammatory 
properties induced us to use a higher concentration. Preliminary test were made to 
evaluate the effect of AF-16 on the basal Isc. As shown by Figure 5, AF-16 applied to 
basolateral bathing solution led to a slow increase of Isc. Diphenylamine 2-carboxylic 
acid is a non specific Cl- channels blocker and a voltage-dependent CFTR/Cl- blocker, 
which is thought to be the primary pathway for Cl- and hence intestinal fluid secretion in 
c-AMP mediated diarrhoeas (Thiagarajah and Verkman, 2003). Applied after the AF-16 
treatment DPC (2mM) reduced Isc by 30%, (Figure 6).  
 
 
Figure 6. Effect of apical administration of DPC (2mM) on Isc of IPEC cells which 
were treated apically with AF-16 (5.7x10-4 M). 
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Effects of AF-16 on CT-stimulated Isc. The capability of AF-16 (5.7x10-4M) on CT-
induced (1 μg/ml) increase of Isc was studied. Depicted in Figure7 are the results from 
the experiments were CT and AF were administrated simultaneously. AF administration 
at both sides before and during the toxin treatment caused a slowly mounting increase in 
Isc (ΔIsc=2.03 and ΔIsc=1.79 μA/cm2, respectively). When AF-16 was replaced by the 
bathing solution at the basolateral side, Isc increased faster +ΔIsc= 5.99 μA/cm2, (+ 
41% vs + 9%) see Table 2. The current increase was drastically blocked by DPC (2mM) 
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 applied at the apical side: Isc lowered immediately by 30% (ΔIsc= - 4.69 μA/cm2). 
When AF-16 was administrated after CT treatment, the same trend on Isc increase was 
noted since AF-16 reduced the rate by which Isc increased, but it did not cause a 
reduction of Isc (Figure 8). 
 
Figure 7. Effect of AF-16 (5.7x10-4 M) added to both sides before CT challenge (1 
μg/ml) and only at the basolateral side after the toxin challenge. DPC (2mM) was added 
apically at the end of the test to evaluate its effect on CT-induced anion secretion. 
 
0 20 40 60 80 100 120 140 160
CT 1 gml
DPC 2mM
A/cm2
Isc
AF-16 
5.7x10-4 M
Time       min
K-R
AF-16
0
10
20
30
 
 
Table 2. Average Isc values and Δ Isc referred to Figure 7: AF-16 (5.7x10-4 M) was 
initially added to both sides. During and after CT challenge (1 μg/ml) the peptide was 
added only at the basolateral side. P value of Δ Isc reported under the table. 
 
 Isc  μA/cm2 Basal AF CT +AF CT1 CT+AF CT2 DPC 
Average Isc 6.83 8.10 9.85 13.62 19.25 20.38 15.68 
SD 0.50 0.48 1.03 2.26 0.89 3.29 0.11 
Δ Isc 1.46 1.39 2.03 5.99 1.79 4.65 -4.69 
  
Basal vs AF        P< 0.001;          AF vs CT+AF     P< 0.01;  
CT+AF vs CT1     P< 0.001;          CT1 vs CT+AF   P< 0.001; 
CT+AF vs CT2     P< 0.001;          CT2 vs DPC      P< 0.01; 
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 Figure 8. Effect of AF-16 (5.7x10-4 M) added to both basolateral and apical bathing 
solution and DPC (2mM) on CT-induced (1 μg/ml) Isc. 
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Table 3. Average Isc values and Δ Isc referred to Figure 8: AF-16 (5.7x10-4 M) was 
added to both sides during CT challenge (1 μg/ml) and only at the apical side after the 
toxin treatment. P value of Δ Isc reported under the table. 
 
Isc  μA/cm2 Basal CT CT +AF AF DPC 
Average Isc 7.170 9.768 15.296 18.599 17.480 
SD 0.39 2.00 0.90 1.32 1.56 
Δ Isc 2.938 6.723 3.152 4.018 5.045 
 Basal vs CT  P< 0.001; CT vs CT+AF P< 0.001;         
 CT+AF vs AF P< 0.001;          AF vs DPC P< 0.01; 
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 Discussion 
 
Bacterial infections can cause severe fluid accumulation that may be associated to life 
threatening dehydratation. The bacterial enterotoxins stimulate secretion from crypt 
epithelial cells with luminally directed active transport of anions, mainly chloride and 
bicarbonate, which is the driving force for fluid secretion. However, when secretion 
increases beyond the ability of the colon to reabsorb water and electrolytes, it results in 
diarrhoea that may lead to severe dehydration if not treated in a timely manner. 
AF-16 contains the active region of the human antisecretory protein. As previously 
discussed, the antisecretory factor has a strong antisecretory activity in vivo. Immuno-
histochemical analysis and experimental evidences suggest the involvement of the 
nervous system in the AF-mediated antisecretory action. Electrophysiological studies on 
Deiter’s cell membranes showed that AF-derived peptides, which were actives as 
antisecretory molecules in a rat in vivo model, inhibited GABA and chloride permeation 
(Rapallino et al., 2003). As reported before in the text, bicuculline blocks the effect of 
AF on Deiters’ cells, suggesting that AF acts via the GABAA receptor (Lange et al., 
1987). 
According to Rapallino et al. (2003), AF and its derivatives counteracted intestinal 
hypersecretion by blocking the permeation of anions, with a possible inhibitory effect 
on the generation of action potentials in enteric nerve cells, which control the intestinal 
water and ion transport system. 
Indeed, the intestinal secretion is controlled by local nervous reflexes and likely 
involves GABAergic neurons. GABA, acting on GABAA receptors, has a depolarizing 
and excitatory in the enteric nervous system. Kim et al. (2005) hypothesized that AF 
may act at the level of the enteric nervous system as a modulator of GABAergic 
transmissions in the gut, counteracting hypersecretion by decreasing the activity in 
secretory reflexes. The GABAA receptor agonists are known to act as secretagogues, 
whereas the GABAA receptor blockers exert antisecretory effects (MacNaughton et al., 
1996). According to Kim and co-workers (2005) AF does not appear to be a general 
GABA antagonist or agonist.  
In the in vitro experiments here presented, AF-16 did not inhibit the toxin-induced 
hypersecretion in cultured IPEC cells, thus supporting the hypothesis of a neuronal-
mediated activity of AF. Indeed the results demonstrated that secretory responses, 
induced by application of CT into the mucosal bathing media were reduced by AF, but 
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 not suppressed. As reported by Li et al. (2003), cholera toxin and AF receptors are co-
localized in the lipid raft of cell membrane. It is possible speculate that the reduced 
increase rate of CT-induced Isc observed during simultaneous administration of CT and 
AF-16, might be due to a kind of steric “disturbing effect” of AF-16 binding to its 
receptor flotillin-1, as suggested by Johansson et al. (2008). Although the effects of AF-
16 on CT-stimulated Isc observed were significative (P= 0.001), it is difficult to find an 
explanation to our observation, since it is well known that the Ussing chamber 
technique performed with polarized cell monolayer has some limitation. More trials are 
required to define the direct effect of AF exogenous in the intestinal lumen, i.e. as 
consequences of AF-rich products administration, on enterocytes. In vitro studies with 
intestinal mucosa provided with outer muscles layers are necessary to elucidate which 
neuronal structures of the enteric nervous system are involved in the antisecretory 
activity of this multi-functional protein. 
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 In vitro assessment of anti-inflammatory activity of AF-16 
  
 
The immune system has been conventionally divided into innate immunity and adaptive 
immunity. The innate immune system non-specifically recognises foreign antigens and 
constitutes the first line of defence of the organism. It consists of cells such as 
polymorphonuclear leucocytes, mononuclear phagocytes, dendritic cells, mast cells and 
platelets. Moreover, humoral inflammatory mediators such as complement components 
are involved in the nonspecific response.  
The adaptive cellular immune system consists of B and T lymphocytes, characterised by 
the presence of different receptors and can thus specifically recognise antigens.  
Macrophages play a role in both the innate and the adaptive immune system. In the 
acquired immune system, macrophages act as antigen presenting cells (APCs) while in 
the innate immune system, they act as phagocytic cells and release different biologically 
active molecules such as oxygen and nitrogen radicals (Kròl et al., 1995). Therefore, 
macrophages provide a link between the innate and adaptive immune response. During 
inflammatory reactions, macrophages have 3 major tasks: antigen presentation, 
phagocytosis and immunomodualtion through production of a variety of cytokines and 
“growth factors” (Fujiwara and Kobayashi, 2005). 
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are known to play 
a double role in biological systems, since they can be both harmful and beneficial to the 
organism (Valko et al. 2006).  
NO is a critical mediator of inflammation and it is released by different cell types such 
as activated macrophage (Hibbs et al., 1988; Azadmehr et al., 2009; MacMicking et al., 
1997). Nitric oxide (NO) is a short-life free radical synthesized from arginine that has a 
regulator/mediator role in several biological processes, including host defence, 
neurotransmission, blood vessel dilatation and platelet aggregation (Moncada et al., 
1991; Nathan, 1992).  
Under physiological conditions, NO mediates anti-inflammatory reactions in order to 
prevent autoimmunity, although it may exert regulatory or cytotoxic effects depending 
on the concentration acting on the target cell (Stuehr and Nathan, 1989). Excessive NO 
production has been related with chronic inflammatory diseases, septic shock and 
autoimmune diseases (MacMicking et al., 1995; Guzik et al., 2003).  
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 Reactive oxygen species (ROS), such as superoxide anion (O2−) and hydrogen peroxide 
(H2O2) are commonly produced during inflammatory processes and play an important 
role in host defence against infections. Phagocytosis and the capability to initiate a 
respiratory burst by producing ROS, are the main cytotoxic properties of phagocytes 
(Miller and Britigan, 1997). At moderate concentrations, ROS play an important role in 
redox homeostasis as regulatory mediators in the signaling pathways and in maintaining 
physiological cell processes and functions (Dröge, 2002). However, when cellular 
production of ROS overwhelms its antioxidant capacity a state of oxidative stress is 
reached, leading to serious cellular injuries and contributing to the pathogenesis of 
several diseases. As previously discussed, the endogenous AF protein counteracted 
inflammation and abnormal fluid transport in relation to intestinal diarrheal diseases 
(Björck et al., 2000; Lange and Lönnroth, 2001), and Ménière's disease (Hanner et al., 
2004). The immunohistological distribution of AF suggests that this protein may play a 
role in the immune system as a neuromodulator and a potent anti-inflammatory agent. 
In rat jejunal loops, AF inhibited the inflammatory response caused by toxin A from 
Clostridium difficile (Björck et al., 2000). AF has been reported to counteract 
inflammatory reactions in experimental autoimmune encephalomyelitis (EAE). 
Davidson and Hickey (2004a, 2004b) hypothesized that the increased AF expression 
observed in rats during the course of EAE could be a means of counteracting the pro-
inflammatory environment and of limiting the tissue damage. We tested the AF-16 
peptide anti-inflammatory activity in cultured macrophages challenged with 
inflammatory stimuli. The lipopolysaccharide (LPS)-challenged RAW 264.7 murine 
macrophages and phorbol myristate acetate (PMA)-challenged pig alveolar 
macrophages were used as model system.  
All the in vitro experiments were performed at the Katholieke Universiteit of Leuven 
under the guidance of Prof. T.A. Niewold. 
 
Materials and methods 
 
Test substance 
The AF-16 peptide (VCHSK TRSNP ENNVG L, m.w. 1754.95), synthesized by 
ordinary solid phase technique, was generously provided by Prof. Lange of the 
Goteborg University (SW).  
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 The peptide was carefully dissolved to a concentration of 1mg/ml in MilliQ water, 
divided into aliquots of 50 μl and stored at -20°C until use. 
The molar AF-16 concentrations used to perform the NO assay were (M):1x10-4, 1x10-5, 
1x10-6, 1x10-7, 1x10-8, 1x10-9.  
ROS test was performed using the following concentrations (M): 1x10-5, 1x10-7, 1x10-9. 
 
Nitric oxide assay 
In RAW 264.7 cells, LPS induces inducible nitric oxide synthase (iNOS), and then NO 
production. Therefore, this macrophage cell line provides an excellent model for the 
evaluation of AF-16 as potential inhibitor of the pathway leading to the induction of 
iNOS. The reactive free radical NO synthesized by iNOS is a major macrophage-
derived inflammatory mediator and has been reported to be involved in the development 
of inflammatory diseases. NO released from cells can be detected and quantified 
photometrically, as its stable product nitrite, by a simple colorimetric reaction (Griess 
reaction). 
 
Cell Culture 
Murine macrophage RAW 264.7 cell line, obtained from the American Type Culture 
Collection, was cultured in antibiotic free Dulbecco Modified Eagle Medium (DMEM 
+4mM L- glutamine, 4.5 g/l glucose, GIBCO) with 10% heat-inactivated fetal bovine 
serum and 2% of NaCO3, at 37 °C under 5% CO2.  
Before performing the tests, cell viability was assayed by trypan blue exclusion test, 
based on the principle that live cells possess intact cell membranes that exclude certain 
dyes, such as trypan blue, whereas dead cells do not. Briefly, 10 μl of cell suspension 
were dissolved in 90 μl of trypan blue solution and mixed. A drop of the solution was 
placed on a Burker chamber and cells were observed and counted under a binocular 
microscope.     
 
Reagents 
The AF-16 solutions with known peptide concentration used to perform the test were 
always prepared fresh in DMEM medium supplemented with 10% of FBS. 
Lipopolysaccharide (LPS) stock solution (5 mg/ml in milliQ water) was diluted with 
medium to a final concentration of 50 ngLPS/ml. The NaNO2 stock solution was 
obtained by dissolving 690 mg of NaNO2 in 10 ml of RAW cell medium, to obtain a 
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 1M concentration. The stock solution was serially diluted with medium to obtain the 
known molar concentration of NaNO2 for the calibration curve: 100-50-25-12, 5-6.25-
3.13-1.56 and 0µlM.  Oxytetracycline (OTC; Sigma Chemical Co., St. Louis, MO, 
USA) was used as positive control in the plate (700µg of OTC in 10 ml of medium). 
GRIESS-reagent used was a ready stock reagent (Sigma Chemical Co., St. Louis, MO, 
USA). 
 
Experimental protocol 
The grown RAW cells were removed from the culture flask, transferred to falcon tubes 
(50 ml) and centrifuged for 10’ at 1500 rpm. The pellet was resolved in fresh medium: 
cells were counted and diluted to a final concentration of 1x106 cells/ml. After that, 100 
μl of cell suspension (1x106 cells/ml) were seeded in a 96-well microtiter plate and 
incubated for 24 hours at 37°C in 5%CO2 humified atmosphere. At the end of 
incubation, the medium was removed and, following the experimental schedule, 50 μl 
of fresh medium or medium with various AF-16 concentrations were added to the wells. 
The plate was then incubated for 4h at 37°C in 5%CO2 atmosphere. OTC was used as 
positive control in the last two rows of the plate. The incubation time for OTC was 10 
minutes. In order to stimulate the inflammatory response by cultured macrophages, 50 
μl of fresh medium with LPS (10 ng/ml) were added to the wells, following the 
experimental schedule (Figure 1). The plate was incubated for 24h at 37°C in 5%CO2 
atmosphere. After challenge with LPS, aliquots of cell culture supernatant (100 μl) were 
transferred to a new plate and mixed with 100 μl of Griess reagent. The plate was then 
incubated at room temperature for 10 min. Sodium nitrite was used to generate a 
standard curve and the nitrite concentration was determined by measuring the optical 
density at 540 nm with a Wallac Victor2 1420 Multilabel Counter. Assays were 
performed in quadruplicate. 
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Figure 1. Plate scheme used for NO assay. 
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Reactive Oxygen Species Assay 
Reactive oxygen species (ROS) are known to play important roles in cellular systems, 
they are fundamental in the clearance of invading microorganisms by phagocytes of the 
innate immune cells. 
Stimulation with phorbol myristate acetate (PMA) induces ROS release by alveolar 
macrophages.  
The fluorescent probe dihydrorhodamine 123 (DHR) has been shown to respond to a 
number of species including superoxide, hydrogen peroxide and peroxynitrite, which 
oxidize DHR123 to yield the fluorescent product rhodamine 123 (Henderson et al., 
2009). The fluorescence observed is therefore directly proportional to intracellular 
concentrations of ROS. 
 
Cell culture 
Alveolar macrophages (AMs) were isolated from the lungs of piglets as described by 
Ure at al. (2002). Briefly, lungs were aseptically removed from euthanized pigs. A 
funnel was placed in the trachea and 200 ml of PBS were poured into the lungs. The 
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 lungs were gently massaged, the lavage fluid was collected into sterile falcon tubes (50 
ml), immediately put on ice. The procedure was repeated two more times and the tubes 
were centrifuged at 1500 rpm for 10 minutes at 4°C. The supernatant was removed and 
the pellet was resolved in PBS and centrifuged at the same conditions to eliminate the 
erythrocytes. Macrophage cells were resolved in RPMI 1640 medium (Sigma Aldrich, 
St. Louis, MO) with 10% FBS (GIBCO) and 1% of antibiotic/antimycotic (10 mg 
streptomycine and 25 μg amphotericine per ml, Sigma Aldrich, St. Louis, MO). The cell 
viability was evaluated with the trypan blue dye exclusion test (>95%). The purity and 
morphology of AMs was determined by May-Grünwald-Giemsa staining of air-dried 
cytospin smears. The cells were counted, divided into aliquots and stored in liquid 
nitrogen until use. 
 
Reagents 
Phorbol 12-myristate 13-acetate (PMA) (Sigma, St. Louis, MO) was dissolved in 
dimethyl-sulfoxyde (DMSO) to obtain a stock solution (10-3 M) and further diluted in 
Hanks balanced salt solution (HBSS) before use. Dihydrorhodamine 123 (DHR, 
Molecular Probes Europe, Leiden, The Netherlands) stock solution (2.5 mg / ml in 
DMSO) was diluted in HBSS before use. 
 
Experimental protocol 
Tests were performed using a cell suspension with a final concentration of 1x106 
cells/ml. 
Briefly, 50 μl of cell suspension were seeded in a microtiter black plate. The plate was 
incubated for 2 hours at 37°C in 5%CO2 atmosphere, to allow cells adhesion to the 
wells bottom.  
After incubation the supernatant was removed with a multichannel pipette and 50 μl of 
medium with or not variuos AF-16 concentrations were added to the wells following the 
experiment scheme (Figure 2). The plate was incubated for two hours at the same 
temperature and atmosphere conditions. After that, wells were rinsed with 100 μl heated 
HBSS. The rinsing step was repeated 3 times. 
Following the experiment schedule, 50 μl HBSS or 50 μl medium containing PMA were 
added to the wells. The plate was wrapt with an aluminium foil and incubated for 15’ at 
37°C on a plate shaker. After the first step, 50 μl HBSS or 50 μl DHR were added to the 
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 wells (Figure 2) and the wrapt plate was incubated at the same conditions for 25 
minutes.  
Production of intracellular ROS was measured by the fluorescence dye 
dihydrorhodamine-123. Fluorescence was measured using a Victor 1420 Multilabel 
Counter, with excitation at 488 nm and emission at 530 nm.  
 
Figure 2. Plate scheme used for ROS assay. 
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Results and Discussion 
 
As previously reported, the antisecretory factor is expressed by cells of the immune 
system, primarily macrophages, and appears to regulate the immune response. 
Furthermore, the expression levels and distribution of AF are markedly altered during 
an immunological response. According to Davidson and Hickey (2004b), in vitro 
administration of TLD-1A8A antibody that specifically recognizes AF, resulted in 
increased proliferation of memory/effector T cells. In a rat model of experimentally 
induced autoimmune encephalomyelitis, administration of anti-AF antibody enhanced 
the severity of the symptoms and increased the proinflammatory cytokines production 
(Davidson and Hickey, 2004a).  
The anti-inflammatory activity of the antisecretory factor has been reported by 
Johansson et al. (1997) who found that AF, at picomolar concentration, abolished 
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 cytoxic and inflammatory reactions in intestinal mucosa of rats challenged with Toxin 
A from C. difficile. 
AF-rich egg yolk provided to patients affected by chronic inflammatory bowel disease, 
as a supplement to conventional pharmacological therapy, was found to improve 
inflammation, as demonstrated by rectal biopsies (Eriksson et al., 2003).  In this work 
the in vitro anti-inflammatory activity of AF-16, at different concentrations, on 
stimulated macrophages was investigated. Macrophages play a critical role in the 
initiation, maintenance, and resolution of inflammation. Upon activation, macrophages 
release a set of primary inflammatory mediators involved in both beneficial and 
detrimental outcomes in inflammation. LPS, as an outer membrane component of 
bacteria, triggers the secretion of nitric oxide, which is extremely reactive and has a 
wide range of physiological activities involved in the immune response (Ignarro, 2002). 
The large amount of NO produced in response to bacterial lipopolysaccharide plays an 
important role in endotoxemia and inflammatory conditions (Bellot et al., 1996). In this 
experiment, the basal NO production of the RAW 264.7 culture, in absence of drugs, 
was 0.76± 0.10 μM (n=8). In agreement with the data of others (Shen et al., 2002; 
Wadsworth et al., 2001), we found a huge NO release by LPS-stimulated cells as 
opposed to untreated control. It was found that AF-16 treatment reduced nitric oxide 
production by LPS-stimulated macrophages in a dose depend fashion, with major 
effects observed at the highest dosages (10-4 and 10-5 M, P< 0.05), see Table 1. AF-16 
showed a mild anti-inflammatory effect only at the highest dosage. Indeed, nitric oxide 
production by LPS-stimulated macrophages was significatively reduced only by AF-16 
at 10-4 M, (28.01 vs 32.17 μM, P< 0.05). As shown by Figure 3, NO production by 
activated macrophages was also reduced by AF-16 used at lower concentration, though 
the differences with the control were not significant.  
The mild anti-inflammatory activity of AF-16 was not confirmed by the ROS assay, 
neither at the highest dosage, (Figure 4). In fact, pre-treatment with various AF-16 
concentrations for 2 h did not significantly reduced the PMA-induced ROS generation 
in pig alveolar macrophages (P< 0.05). In macrophages, like in other cell types, ROS 
influence signalling pathways in diverse ways and participate in the signalling cascade 
triggered by inflammatory mediators, including cytokines and chemoattractants. The 
contradictory results of the tests might be related to errors in the experimental design. 
The alveolar macrophages used to do the experiments were from different piglets, so 
this may be a source of error. The reduction of NO release after AF-16 treatment could 
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 be due to the blockage of LPS activity and consequently the iNOS inhibition. 
Unfortunately this enzyme was not determined in our experiment. 
 
Figure 3. Evaluation of AF-16 effects of NO production by LPS stimulated RAW 264.7 
macrophages. AF-16 reduced LPS-induced release of NO at the higher doses. Values 
are mean ± SEM of 6 experiments performed in quadruplicate. * P < 0.05 compared 
with untreated control. 
 
 
Moreover, the presence in AF-16 of cysteine, which contains a SH group, and proline, 
which is a well known free-radicals scavenger, might have acted as a scavenger for 
unpaired electrons, thus reducing free radicals generation (Sunman et al., 1993; Nunes 
et al., 1995). Since NO is a vasodilatative molecule, a reduction in its synthesis fit well 
with the in vivo reduction of gut permeability in cholera-challenged rats after AF 
administration (Lange et al., 1998). NO synthesized normally diverts O.2 from ROS 
pool to produce peroxynitrite and reduce ROS concentration (Chabot et al., 1998). 
However the lack of evidence about an effect of AF on ROS production could not be 
explained in this way because pigs alveolar macrophages do not produce NO 
(Zelnickova et al., 2008). 
 98
 Table 1. NO production (μM) by RAW 264.7 macrophages grown with different  
 amounts of antisecretory factor (AF).s) 
 
 
 
 
AF concentration (μM)     
CTRL 10-4 10-5 10-6 10-7 10-8 10-9 SEM Linear Quadratic Cubic 
32.17bc 28.01a 29.16ab 30.63ab 32.15bc 33.81b 32.86bc 1.64 0.0167 0.4288 0.4166
a,b,c (P<0.05) 
 
 
 
 
 
 
        
 
Figure 4. Production of intracellular ROS in pig alveolar macrophages, stimulated by 
PMA, after 2 h of incubation with different concentration of AF-16. Values are mean ± 
SEM of 6 experiments performed in duplicate. There were no significative differences 
between treatment and between treatment and control. P < 0.05 compared with 
untreated control. 
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 General Discussion and Conclusions 
 
In recent years, nutrient supply has ceased to be the main goal of nutrition, both for 
humans and animals. Foods and feeds are now considered as possible tools to improve 
health and wellness. Well-known foods like grains, tomatoes, or milk are studied for 
health promoting activity of nutrients such as β-glucans, lignans, lycopene or 
conjugated linoleic acid.  
In pig intensive husbandry nutritional, social and environmental stresses are common, 
particularly at weaning. For more than 50 years, AGP provided a protection against the 
negative effects associated to intensive breeding practices on animals’ health, and 
permitted better growth performance. After the AGPs complete ban in European Union, 
the detrimental effects observed on piglets health and growth performances prompted 
the research for new feed additives. New nutritional and management strategies, aimed 
to reducing the economic loss caused by increased production length and higher 
veterinary expenses, have also gained interest. 
So far, none of the substances proposed is as satisfactory as the in-feed antimicrobials. 
According to Piè et al. (2004), weaning in piglets is associated with a transient 
inflammatory response that may contribute to both anatomical and functional intestinal 
disorders in piglets.  
Therefore, immunomodulating compounds are gaining interest, since the correct 
development of both innate and acquired immune system of the piglets is strategic in 
determining the outcomes of a large exposure to antigens and stress conditions, 
especially in intensive farming (Gallois et al., 2009). AF-inducing diets such as the 
hydrothermally processed cereals appear to be suitable candidates as replacers of 
antibiotic growth promoters. Lönnroth et al. (1988) found a correlation between AF 
concentration in milk and incidence of diarrhoea in the offspring. 
In vitro and clinical studies evidenced its potent capability to counteract intestinal fluid 
imbalance of various aetiologies, meanwhile recent reports focused on its 
immunomodulatory and anti-inflammatory properties.  
We tested the effect of two different HPC level of inclusion in a wheat-barley based diet 
fed to weaned piglets growth performance, reared in an experimental farm. The results 
from the field trial confirmed the efficacy of the HPC as growth promoters in piglet 
nutrition: compared to the 3% supplemented diet and the control group, 6% of HPC 
supplementation improved average daily gain and feed conversion rate. The growth 
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 improvement observed might be explained by two theories. First, according to 
Göransson (1997) the hydrothermally processed cereals present in the diet might have 
induced higher AF values in piglets plasma. Therefore, given the physiological 
inflammatory state of the intestinal mucosa, AF might have exerted an anti-
inflammatory activity due to the down-regulation of the immune response. The energies 
saved might be conveyed to growth. However, the trial was conducted in an 
experimental facility, with optimal sanitary conditions and both blood haptoglobin and 
I-FABP were low for all the piglets.  
The differences in growth performance between HPC-fed piglets and the control group 
might due to a balanced supply of energy-yielding nutrients and amino acids. The in 
vitro digestion assays evidenced relevant simple sugars content and a higher rate of 
starch degradability in the HPC diets compared to the control. Starch in cereals has a 
great importance in newly weaned piglets since it constitutes the largest portion of the 
diet and is the major energy-yielding component, so the rate of starch digestion is a 
crucial characteristic that rules the dietary energy value of compound diets (Wiseman, 
2006; White et al., 2008). The first week after weaning is characterized by reduced feed 
intake and reduced pancreatic enzymes activity, therefore feeding a diet with highly 
digestible starch guarantees a correct amount of energy, limiting the amount of starch 
available for microbial fermentation in caecum and colon.  
In vitro test were made to improve our knowledge about the antisecretory and anti-
inflammatory properties of the AF protein and its mechanism of action by using AF-16, 
a16-meric peptide defined as the active region of the protein.  
The Ussing chamber provides a valuable, time-proven method for the measurement of 
electrolyte, nutrient, and drug transport across epithelial tissues (Clarke, 2009). This is a 
useful tool to study the effects of alternatives to in-feed antibiotics applied to the 
animals in vivo. 
The Ussing chamber experiments performed on polarized IPEC-J2 cells confirmed the 
neuronal involvement in the antisecretory activity of AF. In fact, AF-16 did not inhibit 
CT-induced Isc increase as did DPC, a voltage-dependent CFTR/Cl- blocker. A slower 
rate of Isc increase was observed during the simultaneous administration with AF-16 
and CT.  
A recent study by Johansson et al. (2008) hypothesized that AF binding to the integral 
membrane protein flotillin-1, localized in the lipid rafts, causes an alteration of ion 
channels and receptors localization. It is possible to speculate that the effects observed 
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 on CT-induced Isc might be due to a kind of “disturbing effect” on the toxin binding to 
GM1, which is also localized in the lipid rafts. However, it is difficult to find a correct 
explanation to our observation, since the Ussing chamber technique performed on 
polarized cell monolayer has some limitation. As reported by Clarke (2009), polarized 
cell monolayers produce lower responses in transport function compared with epithelial 
cells layer of the native intestine because of the reduced number of available epithelial 
cells within the same surface area. Also the microscopic architecture of the intestine 
contributes to the alterations in drug responses by the epithelium.  
Furthermore, cholera toxin requires a long time to exert its effect on Isc, while the 
monolayer cells have not a long viability. More in vitro experiments are required to 
define which are the direct effects of exogenous AF, due to AF-rich products intake, or 
those related to endogenous AF, i.e. induced by HPC, on the enterocytes. In vitro 
studies on the intestinal mucosa, provided with outer muscles layers, are necessary to 
elucidate which neuronal structures of the enteric nervous system are involved in the 
antisecretory activity of this multi-functional protein. 
As mentioned above, the intestinal mucosa has been defined an organ in state of 
constant and controlled inflammation, processes that require a high energy expenditure 
(McDonald and Monteleone, 2005).  
Hyckey and Davidson (2004a, 2004b) found that AF is expressed in immune system 
cells and that it is able to down regulate the immune response in a rat model of 
encephalomyelitis. 
 To evaluate the anti-inflammatory activity of AF, as a possible immunomodulating 
feed additive, two kind of in vitro assays were made. 
High dosages of AF-16 were found to reduce the LPS-stimulated NO production in 
RAW264.7 cell, thus supporting the hypothesis of an anti-inflammatory action. The 
effects observed could be due to the blockage of LPS activity and consequently the 
iNOS inhibition. Moreover, the presence in the peptide sequence of cysteine, which 
contains a SH group, and proline, which is a well known free-radicals scavenger, may 
act as a scavenger for unpaired electrons, thus reducing free radicals generation. On the 
contrary, no significant results were obtained on PMA-stimulated ROS generation in 
pig alveolar macrophages. 
The literature review showed how the AF-inducing diets and the AF-therapy is an 
interesting approach to improve welfare in humans affected by several disease 
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 Furthermore, the inclusion of HPC in the diet of lactating women could be exploited in 
order to reduce intestinal disorders in suckling children, particularly in developing 
countries, where breastfeeding is highly recommended and the access to anti-diarrhoeal 
drugs and/or rehydrating solutions are poor. As suggested by Zaman et al. (2007), these 
active cereals can be used as prophylaxis in much exposed populations during the 
diarrhoea season.  
The recent study by Säljö et al. (2009b) showed the effect of diet supplementation with 
HPC on the prevention of harmful effects of exposure to low levels of blast 
overpressure in rats, reducing the extent of intracranial pressure increase and cognitive 
function impairment. So far, there are few studies on the effects of blast related brain 
injuries on brain function in the long term period, but their prevention by dietary tools is 
an interesting perspective. 
Moreover cereals are part of daily food intake in many countries, so it could be easy to 
improve the consumption of active cereals particularly by people exposed to the risk of 
blast related brain injuries, such as soldiers during training session or conflicts (Säljö et 
al., 2009b). Cereals might also be helpful for people subjected to the risk of intracranial 
pressure increase, i.e. patients affected by brain pathologies like tumors in conditions of 
sudden pressure changes, as during long flies, or exposed to overpressure as divers. AF-
rich egg yolk powder gives the opportunity of a direct and fast AF administration to 
young children and to people with impaired food consumption. It is remarkable that the 
hydrothermally processed cereals, being simple cereals kernels, may have a positive 
image towards the modern European consumers, who are increasingly sensitive to 
ethical considerations and whose opinion has a great influence on legislation 
(Florkowsky et al., 1998). Compared to other possible alternatives to antimicrobial 
growth promoters, these processed cereals do not contain any active compound that can 
be lost in the upper gut, since their action is to stimulate the animal capability to 
produce it. In addition, they do not pose any environmental harm such as the use of 
molecules like ZnO, that even with proved growth promoting and anti-diarrhoeic 
properties, accumulates in the soil (Jondreville et al., 2003). In our field trial, we 
showed that the AF-inducing diet improved the feed conversion rate. It is well known 
that a more efficient use of nutrients present in the diets leads to decreased nutrition 
costs and reduced nitrogen and phosphate excretion in manure and their accumulation in 
the soil.  
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